<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">BMC Struct Biol</journal-id><journal-title>BMC Structural Biology</journal-title><issn pub-type="epub">1472-6807</issn><publisher><publisher-name>BioMed Central</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1472-6807-7-55</article-id><article-id pub-id-type="pmid">17725819</article-id><article-id pub-id-type="doi">10.1186/1472-6807-7-55</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Dimerization of inositol monophosphatase <italic>Mycobacterium tuberculosis </italic>SuhB is not constitutive, but induced by binding of the activator Mg<sup>2+</sup></article-title></title-group><contrib-group><contrib id="A1" equal-contrib="yes" contrib-type="author"><name><surname>Brown</surname><given-names>Alistair K</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>a.k.brown.1@bham.ac.uk</email></contrib><contrib id="A2" equal-contrib="yes" contrib-type="author"><name><surname>Meng</surname><given-names>Guoyu</given-names></name><xref ref-type="aff" rid="I1">1</xref><xref ref-type="aff" rid="I4">4</xref><email>ubcg54l@mail.cryst.bbk.ac.uk</email></contrib><contrib id="A3" equal-contrib="yes" contrib-type="author"><name><surname>Ghadbane</surname><given-names>Hemza</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>HXG597@bham.ac.uk</email></contrib><contrib id="A4" contrib-type="author"><name><surname>Scott</surname><given-names>David J</given-names></name><xref ref-type="aff" rid="I2">2</xref><email>dj.scott@nottingham.ac.uk</email></contrib><contrib id="A5" contrib-type="author"><name><surname>Dover</surname><given-names>Lynn G</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>L.G.Dover@bham.ac.uk</email></contrib><contrib id="A6" contrib-type="author"><name><surname>Nigou</surname><given-names>J&#x000e9;r&#x000f4;me</given-names></name><xref ref-type="aff" rid="I3">3</xref><email>jerome.nigou@ipbs.fr</email></contrib><contrib id="A7" corresp="yes" contrib-type="author"><name><surname>Besra</surname><given-names>Gurdyal S</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>G.Besra@bham.ac.uk</email></contrib><contrib id="A8" corresp="yes" contrib-type="author"><name><surname>F&#x000fc;tterer</surname><given-names>Klaus</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>K.Futterer@bham.ac.uk</email></contrib></contrib-group><aff id="I1"><label>1</label>School of Biosciences, The University of Birmingham, Edgbaston, Birmingham B15 2TT, UK</aff><aff id="I2"><label>2</label>National Centre for Macromolecular Hydrodynamics, School of Biosciences, University of Nottingham, Sutton Bonington, LE12 5RD, UK</aff><aff id="I3"><label>3</label>Department of Molecular Mechanisms of Mycobacterial Infections, Institut de Pharmacologie et de Biologie Structurale, Centre National de la Recherche Scientifique Unit&#x000e9; Mixte de Recherche 5089, Toulouse, France</aff><aff id="I4"><label>4</label>Present address : School of Crystallography, Birkbeck College, Malet Street, London WC1E 7HX, UK</aff><pub-date pub-type="collection"><year>2007</year></pub-date><pub-date pub-type="epub"><day>28</day><month>8</month><year>2007</year></pub-date><volume>7</volume><fpage>55</fpage><lpage>55</lpage><ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1472-6807/7/55"/><history><date date-type="received"><day>22</day><month>6</month><year>2007</year></date><date date-type="accepted"><day>28</day><month>8</month><year>2007</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2007 Brown et al; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2007</copyright-year><copyright-holder>Brown et al; licensee BioMed Central Ltd.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0"><p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0"/>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p><!--<rdf xmlns="http://web.resource.org/cc/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1" xmlns:dcterms="http://purl.org/dc/terms"><Work xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" rdf:about=""><license rdf:resource="http://creativecommons.org/licenses/by/2.0"/><dc:type rdf:resource="http://purl.org/dc/dcmitype/Text"/><dc:author> Brown K Alistair a.k.brown.1@bham.ac.uk </dc:author><dc:title> Dimerization of inositol monophosphatase Mycobacterium tuberculosis SuhB is not constitutive, but induced by binding of the activator Mg2+ </dc:title><dc:date>2007</dc:date><dcterms:bibliographicCitation>BMC Structural Biology 7(1): 55-. (2007)</dcterms:bibliographicCitation><dc:identifier type="sici">1472-6807(2007)7:1&#x0003c;55&#x0003e;</dc:identifier><dcterms:isPartOf>urn:ISSN:1472-6807</dcterms:isPartOf><License rdf:about="http://creativecommons.org/licenses/by/2.0"><permits rdf:resource="http://web.resource.org/cc/Reproduction" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/Distribution" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Notice" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Attribution" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/DerivativeWorks" xmlns=""/></License></Work></rdf>--></license></permissions><abstract><sec><title>Background</title><p>The cell wall of <italic>Mycobacterium tuberculosis </italic>contains a wide range of phosphatidyl inositol-based glycolipids that play critical structural roles and, in part, govern pathogen-host interactions. Synthesis of phosphatidyl inositol is dependent on free myo-inositol, generated through dephosphorylation of myo-inositol-1-phosphate by inositol monophosphatase (IMPase). Human IMPase, the putative target of lithium therapy, has been studied extensively, but the function of four IMPase-like genes in <italic>M. tuberculosis </italic>is unclear.</p></sec><sec><title>Results</title><p>We determined the crystal structure, to 2.6 &#x000c5; resolution, of the IMPase <italic>M. tuberculosis </italic>SuhB in the apo form, and analysed self-assembly by analytical ultracentrifugation. Contrary to the paradigm of constitutive dimerization of IMPases, SuhB is predominantly monomeric in the absence of the physiological activator Mg<sup>2+</sup>, in spite of a conserved fold and apparent dimerization in the crystal. However, Mg<sup>2+ </sup>concentrations that result in enzymatic activation of SuhB decisively promote dimerization, with the inhibitor Li<sup>+ </sup>amplifying the effect of Mg<sup>2+</sup>, but failing to induce dimerization on its own.</p></sec><sec><title>Conclusion</title><p>The correlation of Mg<sup>2+</sup>-driven enzymatic activity with dimerization suggests that catalytic activity is linked to the dimer form. Current models of lithium inhibition of IMPases posit that Li<sup>+ </sup>competes for one of three catalytic Mg<sup>2+ </sup>sites in the active site, stabilized by a mobile loop at the dimer interface. Our data suggest that Mg<sup>2+</sup>/Li<sup>+</sup>-induced ordering of this loop may promote dimerization by expanding the dimer interface of SuhB. The dynamic nature of the monomer-dimer equilibrium may also explain the extended concentration range over which Mg<sup>2+ </sup>maintains SuhB activity.</p></sec></abstract></article-meta></front><body><sec><title>Background</title><p>The enzyme inositol monophosphatase (<italic>myo</italic>-inositol-1-phosphate phosphohydrolase, EC 3.1.3.25, IMPase) has attracted considerable scrutiny since the early 1980s. Then, it was discovered that low millimolar concentrations of Li<sup>+ </sup>inhibit IMPase-catalysed dephosphorylation of <italic>myo</italic>-inositol-1-phosphate [<xref ref-type="bibr" rid="B1">1</xref>], which could plausibly explain the marked decrease of <italic>myo</italic>-inositol in brain tissue following administration of lithium, a veteran therapeutic in manic depression treatment [<xref ref-type="bibr" rid="B2">2</xref>]. Inhibition of <italic>myo</italic>-inositol synthesis affects the phosphatidyl inositol second messenger pathway, which is linked to manic depression, and it is now widely accepted, though unproven, that IMPases constitute a major target of lithium therapy [<xref ref-type="bibr" rid="B3">3</xref>].</p><p>The mycobacterial cell wall contains several lipid constituents based on the structure of phosphatidylinositol (PI), such as free PI, phosphatidylinositol-mannosides, lipomannan, and lipoarabinomannan [<xref ref-type="bibr" rid="B4">4</xref>]. In addition to their critical structural role, these lipids are significant as immunomodulatory factors in interactions of the tubercle bacillus with the host [<xref ref-type="bibr" rid="B5">5</xref>-<xref ref-type="bibr" rid="B7">7</xref>]. PI, an essential structural component, is synthesised by phosphatidylinositol synthase, <italic>M. tuberculosis </italic>PgsA, from CDP-diacylglycerol and <italic>myo</italic>-inositol [<xref ref-type="bibr" rid="B8">8</xref>]. In mycobacteria, the supply of <italic>myo</italic>-inositol to PI synthesis is thought to be maintained by <italic>de novo </italic>synthesis, which entails conversion of glucose-6-phosphate to inositol-1-phosphate, catalysed by inositol-1-phosphate synthase, and subsequent dephosphorylation of inositol-1-phosphate catalysed by an IMPase [<xref ref-type="bibr" rid="B9">9</xref>]. Thus, IMPase activity is a critical part of PI biosynthesis in mycobacteria. Indeed, growth of <italic>Mycobacterium smegmatis </italic>is accompanied by IMPase activity that dies off as growth reaches the stationary phase, while growth is retarded in the presence of lithium [<xref ref-type="bibr" rid="B10">10</xref>].</p><p>The <italic>M. tuberculosis </italic>genome encodes four IMPase-like genes (Figure <xref ref-type="fig" rid="F1">1</xref>) [<xref ref-type="bibr" rid="B11">11</xref>,<xref ref-type="bibr" rid="B12">12</xref>], but little is known about the function of the corresponding proteins in terms of <italic>M. tuberculosis </italic>biology. The enzyme most closely related to human IMPase (25% identity), <italic>M. tuberculosis </italic>SuhB (Rv2701c), has been annotated as a 'putative extragenic suppressor protein' according to its homology to <italic>E. coli </italic>SuhB. The <italic>E. coli </italic>enzyme has been implicated in posttranscriptional control of gene expression [<xref ref-type="bibr" rid="B13">13</xref>], but no such function has to date been described for <italic>M. tuberculosis </italic>SuhB. According to the transposon mutagenesis study by Sassetti <italic>et al</italic>., Rv3137 is essential, SuhB is dispensable [<xref ref-type="bibr" rid="B14">14</xref>], and information on essentiality is as yet unavailable for CysQ and ImpA. <italic>In vitro </italic>analyses showed that <italic>M. tuberculosis </italic>CysQ hydrolyses inositol-1-phosphate, adenosine-monophosphate and fructose-1,6-bisphosphate [<xref ref-type="bibr" rid="B15">15</xref>]. In contrast, SuhB appears to be a <italic>bona fide </italic>IMPase with little or no activity towards fructose-1,6-bisphosphate. Still, SuhB also de-phosphorylates a series of polyol phosphates including glucitol-6-phosphate, glycerol-2-phosphate, and 2'-AMP, albeit with significantly reduced efficacy [<xref ref-type="bibr" rid="B12">12</xref>]. Like the human orthologue, SuhB is activated by Mg<sup>2+</sup>, and inhibited by lithium. Nevertheless, SuhB requires higher concentrations of Mg<sup>2+ </sup>for full activation (at ~6 mM), and activity persists over a much wider concentration range (~100 mM) of the activating ion before it becomes inhibitory [<xref ref-type="bibr" rid="B12">12</xref>]. In order to better understand potential functional differences between the mycobacterial and eukaryotic IMPases, we have determined the crystal structure of <italic>M. tuberculosis </italic>SuhB and characterised its self-assembly state in solution.</p><fig position="float" id="F1"><label>Figure 1</label><caption><p><bold>Sequence comparison of <italic>M. tuberculosis </italic>IMPase-like proteins with human IMPase</bold>. Sequences were aligned based on the structural superimposition of SuhB and human IMPase using STRAP [53], and formatted using ESPript [54]. Secondary structure elements of SuhB are above the sequence, cylinders representing helices and arrows &#x003b2;-strands, coloured according to Fig. 2A. Full asterisks denote residues coordinating the catalytic Mg<sup>2+ </sup>sites, triangles indicate residues contacting inositol-1-phosphate in the simulated SuhB-substrate complex. Horizontal boxes indicate disordered parts of the sequence. The grey arrows indicate the positions of strands &#x003b2;1, &#x003b2;2 in the &#x003b1;1-&#x003b1;2 loop ('mobile loop') of human IMPase, with the open asterisk marking the critical lysine residue.</p></caption><graphic xlink:href="1472-6807-7-55-1"/></fig></sec><sec><title>Results</title><sec><title>Structure determination of SuhB</title><p>The structure of M. tuberculosis SuhB was determined by molecular replacement to a resolution of 2.6 &#x000c5; (Table <xref ref-type="table" rid="T1">1</xref>, Figure <xref ref-type="fig" rid="F2">2</xref>). The asymmetric unit of the crystal lattice contains three independent copies of the SuhB monomer forming two crystallographically distinct dimers: chains A and C associate as one dimer, whereas chain B forms an analogous dimer with one of its symmetry mates. The quality of the refined model is limited by several factors: first, a high Wilson B-factor (77.1 &#x000c5;<sup>2</sup>) of the measured structure factor amplitudes is mirrored by a high average atomic displacement factor (78 &#x000c5;<sup>2</sup>) (Table <xref ref-type="table" rid="T1">1</xref>); second, three disordered loop regions (see below) and mild disorder at either terminus leave 42 of 290 residues of the primary sequence unaccounted for (Figure <xref ref-type="fig" rid="F1">1</xref>); third, despite a nominal resolution of 2.6 &#x000c5; and reasonably strong data in the high-resolution shell (Table <xref ref-type="table" rid="T1">1</xref>), structural details are less well defined by the (calculated) density than expected at this resolution. In order to counteract an unfavourable observables-to-parameter ratio, non-crystallographic symmetry (NCS) restraints were employed, leading to root mean square (RMS) deviations between NCS-related molecules of 0.05 &#x000c5; for backbone and &#x02264; 0.42 &#x000c5; for side chain atoms. Based on visual impression and real space R-factor, the electron density is best defined for subunits A and C, and worst for subunit B.</p><table-wrap position="float" id="T1"><label>Table 1</label><caption><p>Crystallographic statistics</p></caption><table frame="hsides" rules="groups"><tbody><tr><td align="left">Beamline</td><td align="left">ID14-2 (ESRF, Grenoble)</td></tr><tr><td align="left">Wavelength (&#x000c5;)</td><td align="left">0.933</td></tr><tr><td align="left">Space group</td><td align="left"><italic>C</italic>222<sub>1</sub></td></tr><tr><td align="left">Unit cell parameters</td><td></td></tr><tr><td align="left">a, b, c (&#x000c5;)</td><td align="left">101.5, 185.4, 106.9</td></tr><tr><td align="left">Resolution range (&#x000c5;)</td><td align="left">20&#x02013;2.60 (2.69&#x02013;2.60)<sup>a</sup></td></tr><tr><td align="left">Unique reflections</td><td align="left">30931 (3028)</td></tr><tr><td align="left">Completeness (%)</td><td align="left">98.7 (97.4)</td></tr><tr><td align="left">&#x0003c; I/&#x003c3;(I) &#x0003e;</td><td align="left">24.5 (2.5)</td></tr><tr><td align="left">Multiplicity</td><td align="left">4.9 (3.8)</td></tr><tr><td align="left">Rsym<sup>b </sup>(%)</td><td align="left">6.8 (25.8)</td></tr><tr><td align="left">Rcryst/Rfree<sup>c </sup>(%)</td><td align="left">22.3/24.5</td></tr><tr><td align="left">No. of non-hydrogen atoms</td><td align="left">5466</td></tr><tr><td align="left">Protein</td><td align="left">5342</td></tr><tr><td align="left">Solvent</td><td align="left">124</td></tr><tr><td align="left">Average B-factors (&#x000c5;<sup>2</sup>)</td><td align="left">78</td></tr><tr><td align="left">Main chain &#x02013; subunit A/B/C</td><td align="left">68/89/72</td></tr><tr><td align="left">Side-chain &#x02013; subunit A/B/C</td><td align="left">71/91/76</td></tr><tr><td align="left">Solvent</td><td align="left">81</td></tr><tr><td align="left">Wilson B-factor</td><td align="left">77.1</td></tr><tr><td align="left">RMSD bonds (&#x000c5;)</td><td align="left">0.011</td></tr><tr><td align="left">RMSD angles (&#x000b0;)</td><td align="left">1.26</td></tr><tr><td align="left">Ramachandran statistics<sup>d</sup></td><td></td></tr><tr><td align="left">Core</td><td align="left">91.4%</td></tr><tr><td align="left">Allowed</td><td align="left">7.9%</td></tr><tr><td align="left">Generous</td><td align="left">0.7%</td></tr><tr><td align="left">Disallowed</td><td align="left">None</td></tr></tbody></table><table-wrap-foot><p><sup>a </sup>Numbers in parenthesis refer to the outer resolution bin.</p><p><sup>b </sup>Rsym = &#x003a3;<sub>h</sub>&#x003a3;<sub>i </sub>| I(h, i) - &#x0003c; I(h) &#x0003e;|/&#x003a3;<sub>h</sub>&#x003a3;<sub>i </sub>I(h, i), where I(h, i) is the intensity of the ith measurement of reflection h and &#x0003c; I(h) &#x0003e; is the mean value of I(h, i) for all i measurements.</p><p><sup>c </sup>Rcryst = &#x003a3;<sub>hkl</sub>||Fo| - |Fc||/&#x003a3; |Fo|, where Fo is the observed structure-factor amplitude and Fc the calculated structure-factor amplitude. Rfree is calculated based on 5% of reflections not used in the refinement.</p><p><sup>d </sup>The Ramachandran plot was calculated using <italic>PROCHECK </italic>[43]</p></table-wrap-foot></table-wrap><fig position="float" id="F2"><label>Figure 2</label><caption><p><bold>Fold and crystal dimer of <italic>M. tuberculosis </italic>SuhB</bold>. (<bold>A</bold>) Stereo ribbon diagram of the SuhB monomer, with secondary structure elements coloured according to the penta-layered &#x003b1;&#x003b2;&#x003b1;&#x003b2;&#x003b1;-sandwich arrangement of IMPases (cf. Figure 1). (<bold>B</bold>) Dimer of SuhB formed by subunits A (blue, yellow) and C (lightblue, green). Selected secondary structure elements are labelled for ease of comparison with panel A. Grey spheres indicate boundaries of disordered loops, with corresponding residue numbers in black type. A (modelled) molecule of inositol-1-phosphate in ball-and-stick representation indicates the location of the active site(s) in both panels.</p></caption><graphic xlink:href="1472-6807-7-55-2"/></fig><p>Apart from minor discrepancies, the SuhB monomer is identical in fold to eukaryotic IMPases [<xref ref-type="bibr" rid="B16">16</xref>,<xref ref-type="bibr" rid="B17">17</xref>], with RMS deviations between C&#x003b1; positions of superimposed backbone structures ranging from 1.09 &#x000c5; to 1.15 &#x000c5; (Table <xref ref-type="table" rid="T2">2</xref>). In order to more readily compare SuhB with related structures we denote secondary structure according to the recent report of the 1.4 &#x000c5;-resolution structure of bovine IMPase (Figures <xref ref-type="fig" rid="F1">1</xref> and <xref ref-type="fig" rid="F2">2A</xref>) [<xref ref-type="bibr" rid="B17">17</xref>]. The IMPase fold is characterised by alternating layers of &#x003b1;-helices and &#x003b2;-sheets in an &#x003b1;-&#x003b2;-&#x003b1;-&#x003b2;-&#x003b1; sandwich arrangement (Figure <xref ref-type="fig" rid="F2">2A</xref>). Comparative studies established that IMPases share a structural scaffold with inositol polyphosphate-1-phosphatases (IPPases), fructose-1,6-biphosphatases (FBPases), 3'-phosphoadenosine-5'-phosphatases (PAPases) and 3'-phosphoadenosine-5'-phosphatase/inositol-1,4-bisphophatases (PIPases) (Table <xref ref-type="table" rid="T2">2</xref>), although on the amino acid sequence level the evolutionary relationship between these groups of enzymes is not obvious [<xref ref-type="bibr" rid="B18">18</xref>-<xref ref-type="bibr" rid="B20">20</xref>]. However, members of this super-family differ notably with respect to their assembly state: eukaryotic IPPases, PAPases and PIPases are monomeric [<xref ref-type="bibr" rid="B19">19</xref>,<xref ref-type="bibr" rid="B21">21</xref>,<xref ref-type="bibr" rid="B22">22</xref>], eukaryotic IMPases form homodimers as do a subset of dual activity IMPase/FBPases [<xref ref-type="bibr" rid="B16">16</xref>,<xref ref-type="bibr" rid="B17">17</xref>,<xref ref-type="bibr" rid="B23">23</xref>-<xref ref-type="bibr" rid="B25">25</xref>], whereas FBPases and the dual activity IMPase/FBPase of <italic>Thermotoga maritima </italic>form tetrameric assemblies [<xref ref-type="bibr" rid="B26">26</xref>,<xref ref-type="bibr" rid="B27">27</xref>].</p><table-wrap position="float" id="T2"><label>Table 2</label><caption><p>Comparison of <italic>M. tuberculosis </italic>SuhB to selected members of the Mg<sup>2+</sup>-dependent/Li<sup>+</sup>-inhibited phosphomonoesterase family of proteins</p></caption><table frame="hsides" rules="groups"><thead><tr><td></td><td align="left" colspan="3">IMPase<sup>c</sup></td><td align="left" colspan="2">FBPase</td><td align="left" colspan="2">IMPase/FBPase</td><td align="left">PAPase</td><td align="left">IPPase</td><td align="left">PiPase</td></tr></thead><tbody><tr><td align="left">PDB ID<sup>a</sup></td><td align="left"><ext-link ext-link-type="pdb" xlink:href="1IMA">1IMA</ext-link></td><td align="left"><ext-link ext-link-type="pdb" xlink:href="2CZH">2CZH</ext-link></td><td align="left"><ext-link ext-link-type="pdb" xlink:href="2BJI">2BJI</ext-link></td><td align="left"><ext-link ext-link-type="pdb" xlink:href="1FBP">1FBP</ext-link></td><td align="left"><ext-link ext-link-type="pdb" xlink:href="1DCU">1DCU</ext-link></td><td align="left"><ext-link ext-link-type="pdb" xlink:href="1LBV">1LBV</ext-link></td><td align="left"><ext-link ext-link-type="pdb" xlink:href="1DK4">1DK4</ext-link></td><td align="left"><ext-link ext-link-type="pdb" xlink:href="1QGX">1QGX</ext-link></td><td align="left"><ext-link ext-link-type="pdb" xlink:href="1INP">1INP</ext-link></td><td align="left"><ext-link ext-link-type="pdb" xlink:href="1JP4">1JP4</ext-link></td></tr><tr><td colspan="11"><hr></hr></td></tr><tr><td align="left">RMSD (&#x000c5;)</td><td align="left">1.09 (197)<sup>b</sup></td><td align="left">1.12 (199)</td><td align="left">1.15 (193)</td><td align="left">1.61 (159)</td><td align="left">1.88 (138)</td><td align="left">1.23 (177)</td><td align="left">1.13 (158)</td><td align="left">1.28 (190)</td><td align="left">1.41 (166)</td><td align="left">1.40 (182)</td></tr></tbody></table><table-wrap-foot><p><sup>a</sup>References for the pdb entries cited in this table are provided in the supplementary information [see Additional file <xref ref-type="supplementary-material" rid="S3">3</xref>].</p><p><sup>b</sup>Number of aligned C&#x003b1; positions.</p><p><sup>c</sup>IMPase (inositol-1-monophosphatase), FBP (fructose-1,6-bisphosphatase), PAPase (3'-phosphoadenosine-5'-phosphatase), IPPase (inositol-polyphosphate-1-phosphatase), PIPase (inositol-polyphosphate-1-phosphatase and 3'-phosphoadenosine-5'-phosphate phosphatase)</p></table-wrap-foot></table-wrap><p>Eukaryotic adenosine-monophosphate (AMP)-regulated FBPases have been described in terms of two sub-domains. In this description, layers I and II of the &#x003b1;-&#x003b2;-&#x003b1;-&#x003b2;-&#x003b1; sandwich are equivalent to the AMP-binding sub-domain of porcine FBPase, and layers III to V correspond to the fructose-1,6-bisphosphate binding sub-domain (Figure <xref ref-type="fig" rid="F2">2A</xref>) [<xref ref-type="bibr" rid="B26">26</xref>]. The primary sequence runs sequentially through layers I and II of the 'AMP-binding' sub-domain, but meanders in the fructose-1,6-bisphosphate-binding sub-domain between layers III-V, with helices and strands alternating. This pattern is interrupted only for strands &#x003b2;12 and &#x003b2;13, which are not separated by a helix (Figures <xref ref-type="fig" rid="F1">1</xref>, <xref ref-type="fig" rid="F2">2A</xref>). The dimer observed in the crystal structure of SuhB is primarily mediated by helices &#x003b1;6 in layer V and the &#x003b2;-sheet in layer IV, which extends across the interface (Figure <xref ref-type="fig" rid="F2">2B</xref>). In contrast, strands in the sheet of layer II are oriented perpendicular to the plane of the dimer interface.</p><p>Due to the absence of divalent metal ions and of substrate in the active site, the loop connecting helices &#x003b1;1 and &#x003b1;2 is disordered (residues 35&#x02013;53 missing), as is much of the loop connecting strands &#x003b2;3 and &#x003b2;4 (residues 85&#x02013;96 missing). Both features are consistent with the structure of the <italic>apo </italic>form of human IMPase (pdb entry <ext-link ext-link-type="pdb" xlink:href="1IMF">1IMF</ext-link>, [<xref ref-type="bibr" rid="B28">28</xref>]). Soaks of SuhB crystals in Mg<sup>2+</sup>- or Mn<sup>2+</sup>-containing cryoprotection buffers failed to induce ordering, or give rise to density peaks associated with metals sites known from the eukaryotic orthologues, which we attribute to the acidic pH (4.1&#x02013;4.5) of the crystallisation buffer. Further disorder was seen in the hairpin loop connecting strands &#x003b2;12 and &#x003b2;13 (residues 254&#x02013;259) in layer IV, while density for the &#x003b2;9-&#x003b1;6 loop was disjointed, yet indicating that the conformation of the loop between residues 183 and 186 differed markedly between subunits. As a consequence, side chains for residues Tyr183, Val185, Arg186 and Cys187 in this loop could not be built.</p></sec><sec><title>Active Site</title><p>The active site of SuhB is situated in a cavity carved out at the N-terminal end of helix &#x003b1;7, sandwiched between layers II and IV (Figure <xref ref-type="fig" rid="F2">2A</xref>). Due to the disordered &#x003b1;1-&#x003b1;2 loop &#x02013; referred to as the 'mobile loop' [<xref ref-type="bibr" rid="B27">27</xref>] &#x02013; the active site in SuhB appears wide open to solvent. Yet, it is anticipated that the &#x003b1;1-&#x003b1;2 loop will become ordered upon the enzyme binding metal ions and substrate. In this state the active site is anticipated to be effectively shielded from solvent, as is the case in the ligand-bound structure of human IMPase [<xref ref-type="bibr" rid="B29">29</xref>]. In SuhB, the &#x003b1;1-&#x003b1;2 loop has a 10-residue insertion relative to human IMPase (Figure <xref ref-type="fig" rid="F1">1</xref>). Hence, the exact conformation of this loop in the ordered state may well deviate from that of the human enzyme. Interestingly, alternative secondary structure conformations of this loop were observed within the tetramer of the structure of <italic>Thermotoga maritima </italic>IMPase/FBPase TM1415. While the mobile loop included a short helix in two subunits of the tetramer, it assumed a &#x003b2;-hairpin conformation in the other two subunits [<xref ref-type="bibr" rid="B27">27</xref>]. The mobile loop includes a lysine residue at position 36 (corresponding to residue 49 in SuhB, marked by I in Figure <xref ref-type="fig" rid="F1">1</xref>) that stabilizes the third of three catalytic metal sites through hydrogen bonds to two ordered water molecules. In SuhB, this lysine is conserved and parallels in the characteristics of Li<sup>+ </sup>inhibition between SuhB and human IMPase (see Discussion) suggest an equivalent pattern of interactions in the mycobacterial enzyme.</p><p>Structural elements of the active site required for metal and substrate binding include the IMPase signature motif <sup>104</sup>DPXDGT<sup>109 </sup>(superscripts denote residue numbers of the SuhB sequence) between strand &#x003b2;4 and helix &#x003b1;4, the <sup>82</sup>GEEG<sup>85 </sup>motif at the 'tip' of the &#x003b2;3-&#x003b2;4 loop, the <sup>209</sup>G [ST]AA<sup>212 </sup>motif in the &#x003b2;10-&#x003b1;7 loop, in addition to Glu228 in &#x003b2;11 and the <sup>234</sup>WDXA<sup>237 </sup>motif in helix &#x003b1;8. All elements contributing to metal site coordination are contained within one subunit of the dimeric assembly. Compelling evidence for three sites occupied by Mg<sup>2+ </sup>was provided only recently by the 1.4 &#x000c5;-structure of bovine IMPase [<xref ref-type="bibr" rid="B17">17</xref>]. This study, in conjunction with preceding structural studies on lithium-sensitive PAPase and lithium-insensitive IMPase/FBPases [<xref ref-type="bibr" rid="B21">21</xref>,<xref ref-type="bibr" rid="B24">24</xref>,<xref ref-type="bibr" rid="B25">25</xref>,<xref ref-type="bibr" rid="B27">27</xref>], provided strong support for a 3-metal catalytic reaction mechanism. When mapped onto the structure of SuhB, these three magnesium ion sites are coordinated by Glu83 (equivalent to residue 70 in human/bovine IMPase: h_70), Asp104 (h_90), Asp107 (h_93), Asp235 (h_220), in addition to the carbonyl of Ile106 (h_92). In a previous study we had shown that mutations to these sites in SuhB reduced activity dramatically [<xref ref-type="bibr" rid="B12">12</xref>]. Likewise, when activity was tested in the presence of various divalent cations, Mg<sup>2+ </sup>was the most potent activator of SuhB. These data and the high level of sequence conservation among active site residues justify the attempt to construct a model of inositol-1-phosphate in the active site of SuhB (Figure <xref ref-type="fig" rid="F3">3A</xref>) and to analyse potential differences in substrate-enzyme contacts.</p><fig position="float" id="F3"><label>Figure 3</label><caption><p><bold>Stereo views of the active site</bold>. (<bold>A</bold>) Active site of subunit A of SuhB, with metal sites (beige) and inositol-1-phosphate (coloured by atom type, carbons in light grey) modelled based on superimposition with the structures of bovine (PDB:<ext-link ext-link-type="pdb" xlink:href="2BJI">2BJI</ext-link>, [17]) and human IMPase (PDB:<ext-link ext-link-type="pdb" xlink:href="1IMA">1IMA</ext-link>, [29]). Residues in contact with metal sites and substrate in the modelled complex are shown as sticks and numbered according to the SuhB sequence. Secondary structure elements are coloured as in Figure 2A. The loop in violet indicates the approximate position of the &#x003b1;1-&#x003b1;2 loop, based on the superposition with PDB:<ext-link ext-link-type="pdb" xlink:href="1IMA">1IMA</ext-link> [29]. (<bold>B</bold>) Bias-free difference density map of the &#x003b2;9-&#x003b1;6 loop in SuhB, calculated after simulated annealing of the model with residues 178&#x02013;188 deleted and contoured at 2&#x003c3;. The density is superimposed with <italic>apo </italic>SuhB (blue sticks) and human IMPase in complex with inositol-1-phosphate (light green, PDB:<ext-link ext-link-type="pdb" xlink:href="1IMA">1IMA</ext-link>, [29]). Putative (grey) and experimental (red) contact distances with substrate are indicated. (<bold>C</bold>) Active site of subunit C of SuhB with &#x003c3;<sub>A</sub>-weighted Fo-Fc map contoured at 3&#x003c3;, showing unexplained density around the putative substrate position and metal site 1.</p></caption><graphic xlink:href="1472-6807-7-55-3"/></fig><p>In our model of the SuhB-substrate complex, the phosphate moiety is positioned at the N-terminal end of helix &#x003b1;4, the helix dipole countering the charge of the phosphate (Figure <xref ref-type="fig" rid="F3">3A</xref>). Most contacts between enzyme and phosphate are through the three Mg<sup>2+ </sup>ions, with contact distances in the order of 2.15&#x02013;2.3 &#x000c5;, in agreement with the experimental structures of the eukaryotic IMPases [<xref ref-type="bibr" rid="B17">17</xref>,<xref ref-type="bibr" rid="B28">28</xref>,<xref ref-type="bibr" rid="B29">29</xref>]. In addition, the phosphate forms H-bond interactions with the amide nitrogen of Gly108 (h_94) and Thr109 (h_95) at the N-terminus of helix &#x003b1;4. The inositol moiety packs primarily against residues in the &#x003b2;9-&#x003b1;6 and &#x003b2;10-&#x003b1;7 loops with specificity-determining contacts provided by Glu228 (h_213) in strand &#x003b2;11, and Asp107 (h_93) in the &#x003b2;4-&#x003b1;4 loop (Figure <xref ref-type="fig" rid="F3">3A</xref>). All conserved side chains forming the metal binding sites or contacting inositol-1-phosphate are seen in essentially the same conformation as in the human/bovine enzyme, with the exception of Glu83: as a consequence of disorder in a large part of the &#x003b2;3-&#x003b2;4 loop, Glu83 (h_70) in subunit A points outward rather into the active site (Figure <xref ref-type="fig" rid="F3">3A</xref>).</p><p>Significant discrepancies between the <italic>M. tuberculosis </italic>and the human enzyme are seen in the &#x003b2;9-&#x003b1;6 loop, which in human IMPase provides a contact surface, but no specificity-determining interactions with the inositol ring [<xref ref-type="bibr" rid="B29">29</xref>] (Figure <xref ref-type="fig" rid="F3">3B</xref>). The &#x003b2;9-&#x003b1;6 loop in SuhB is two residues shorter than in the human enzyme with weak sequence conservation (Figure <xref ref-type="fig" rid="F1">1</xref>). Although poorly ordered between residues 183&#x02013;186, residues in proximity to the putative position of the inositol ring &#x02013; Gly180, Phe181 and Gly182 &#x02013; are well defined by density (Figure <xref ref-type="fig" rid="F3">3B</xref>). Interestingly, the carbonyl oxygen of Phe181 falls within H-bonding distance range of the C3 (2.9 &#x000c5;) and C4 (3.3 &#x000c5;) hydroxyls of the inositol ring, suggesting that the &#x003b2;9-&#x003b1;6 of SuhB may form specificity-determining contacts to the substrate that are not present in the human enzyme.</p><p>A surprising observation was a patch of unexplained density in the active site that overlaps significantly with the modelled position of inositol-1-phosphate, while a second density peak coincides with the metal site 1 (Figure <xref ref-type="fig" rid="F3">3C</xref>) (in the numbering of ref. [<xref ref-type="bibr" rid="B17">17</xref>]). The latter is situated between the carbonyl oxygen of Ile106 and the carboxylate of Asp104 and corresponds to the high-affinity metal site [<xref ref-type="bibr" rid="B17">17</xref>]. The 'metal site 1' peak was present in all three active sites, whereas the density for the inositol-1-phosphate site was best defined in subunit C (Figure <xref ref-type="fig" rid="F3">3C</xref>). We consider it likely that the observed density represents a weakly-bound molecule of octyl &#x003b2;-D-glucopyranoside, a reagent used as an additive during crystallisation. Whether or not the density peak a metal site 1 represents a divalent cation could not be verified.</p></sec><sec><title>Dimer interface and assembly state</title><p>The present crystal structure comprises two apparent dimers of SuhB. One dimer is formed between the NCS-related subunits A and C, while the second dimer results from crystallographic symmetry, pairing two symmetry-related copies of subunit B. As a result of NCS restraints applied during the refinement no substantial difference between the two independent dimers is observed at the interface. The SuhB dimers also superimpose closely with the dimers of the human and bovine IMPase enzymes, whereby the dimer interface is formed by analogous secondary structure elements. These include helix &#x003b1;6, the strand &#x003b2;10, the &#x003b2;9-&#x003b1; 6 loop, helix &#x003b1;4, and the &#x003b2;10-&#x003b1;7 and &#x003b1;7-&#x003b2;11 loops. In the superposition, which is based on secondary structure matching, helices &#x003b1;6 of the two protomers are positioned opposite to each other (Figures <xref ref-type="fig" rid="F2">2B</xref>, <xref ref-type="fig" rid="F4">4A</xref>), contributing approximately 30% of the buried surface area (per monomer). It seems noteworthy that in SuhB the axes of these two helices are spaced 7.5 &#x000c5; apart whereas in the eukaryotic enzymes that spacing is approximately 10 &#x000c5; (Figure <xref ref-type="fig" rid="F4">4A</xref>). The discrepancy can be attributed to alanine residues 192 and 196 being positioned at the centre of this interface (Figure <xref ref-type="fig" rid="F4">4B</xref>), while the side chains of a leucine at position 176 occupy the corresponding space in human IMPase.</p><fig position="float" id="F4"><label>Figure 4</label><caption><p><bold>Analysis of dimer interface</bold>. (<bold>A</bold>) Helices &#x003b1;6 after superimposition of the dimers of human IMPase (cyan) and SuhB (red) by secondary structure matching. The spacing of the helix axes is indicated in units of &#x000c5; and the black oval indicates the position of the non-crystallographic 2-fold axis mapping the subunits onto each other. (<bold>B</bold>) The helix &#x003b1;6 interface in <italic>SuhB </italic>with side chains contributing to the contact surface indicated as sticks in cyan (subunit A) and yellow (subunit C). (<bold>C</bold>) Contact surface (magenta) of subunit A calculated and visualised using Swiss PDB Viewer [50]. The active site indicated by a molecule of inositol-1-phosphate (yellow sticks).</p></caption><graphic xlink:href="1472-6807-7-55-4"/></fig><p>The interface of the SuhB dimer buries a total of 2696 &#x000c5;<sup>2 </sup>of solvent accessible surface, calculated using the <italic>PISA </italic>interface server [<xref ref-type="bibr" rid="B30">30</xref>,<xref ref-type="bibr" rid="B31">31</xref>], or 1348 &#x000c5;<sup>2 </sup>per monomer. In terms of buried surface area hydrophobic interactions clearly dominate over H-bonds (12 contacts). Although the residues located at the interface include a number of polar and charged side chains (Figure <xref ref-type="fig" rid="F4">4C</xref>) only one ionic interaction is seen. In human IMPase distinctly more solvent accessible surface is buried in the interface (1675 &#x000c5;<sup>2 </sup>per monomer). Contacts across the interface include 11 ionic interactions, while the number of H-bonds (13) is about the same as in SuhB. One factor explaining the difference in size of the interface, at least in part, is the disordered 'mobile loop' in SuhB. In the <italic>apo </italic>structure of human IMPase (<ext-link ext-link-type="pdb" xlink:href="1IMF">1IMF</ext-link> &#x02013; [<xref ref-type="bibr" rid="B29">29</xref>]), the &#x003b1;1-&#x003b1;2 loop is also disordered, reducing the total of buried solvent accessible surface per monomer from 1675 &#x000c5;<sup>2 </sup>to 1571 &#x000c5;<sup>2</sup>. Thus disorder of this loop accounts partially for the observed discrepancy.</p><p>The analysis of the dimer interface using the <italic>PISA </italic>server suggested that dimerisation of SuhB might not be constitutive. Based on molecular contacts at the interface, <italic>PISA </italic>calculates a 'complexation significance score' (CSS) that on a scale from 0 to 1 indicates the probability that a packing interface generated by crystal symmetry might represent a 'real' interface [<xref ref-type="bibr" rid="B31">31</xref>]. The CSS for the dimer interface of SuhB is 0.1, compared to a score of 1.0 for the dimer interface of human IMPase (with or without the &#x003b1;1-&#x003b1;2 loop in the ordered state), suggesting that dimerisation was merely due to crystal packing. We analysed self-association of SuhB by analytical ultracentrifugation (AUC) in sedimentation velocity mode. To our surprise, but consistent with the prediction by <italic>PISA</italic>, we found that SuhB is predominantly monomeric, with the peak at molecular weight 30,508 Da closely matching the calculated mass of the SuhB monomer (Figure <xref ref-type="fig" rid="F5">5</xref>). However, with increasing protein concentration a second peak at molecular weight of 54,160 Da appears, and this peak becomes more pronounced, at the expense of the main peak, when 1 mM Mg<sup>2+ </sup>is added to the buffer (Figure <xref ref-type="fig" rid="F5">5</xref>). We verified by SDS gel electrophoresis that the preparation of SuhB used in this experiment did not contain a contaminant that could explain the peak at 54,160 Da (data not shown).</p><fig position="float" id="F5"><label>Figure 5</label><caption><p><bold>Analytical ultracentrifugation in sedimentation velocity mode demonstrates that SuhB is monomeric in the absence of Mg<sup>2+</sup></bold>. Main panel: Traces of the molecular weight distribution of <italic>M. tuberculosis </italic>SuhB in a sedimentation velocity experiment. Conditions analysed were 0.5 mg.ml<sup>-1 </sup>SuhB (solid triangle), 1.0 mg.ml<sup>-1 </sup>SuhB (open triangle),1.0 mg.ml<sup>-1 </sup>SuhB + 1 mM Mg<sup>2+ </sup>(open circle). The main peak is centred at 30,508 Da, the secondary peak at 54,160 Da. Inset: enlarged view of the region between 40,000 and 80,000 Da. Samples were centrifuged at 40,000 rpm, 4&#x000b0;C, for a minimum of 12 hours, in 20 mM Tris-HCl pH 7.9, 50 mM NaCl and MgCl<sub>2 </sub>as indicated.</p></caption><graphic xlink:href="1472-6807-7-55-5"/></fig><p>These data suggested that SuhB, at protein concentrations in the order of 1 mg.ml<sup>-1</sup>, exists in a monomer-dimer equilibrium, but that Mg<sup>2+</sup>, which is required for activity, might shift self assembly to the dimer state. The underestimate in molecular weight of the dimer peak is due to the fitting of a single frictional coefficient to two species that have differing frictional ratios. In addition, the appearance of two separate peaks in the molecular weight profile with increasing concentration indicates that the off-rate for dimerisation is slow compared with the time of sedimentation. Values for the off-rate for this regime are therefore estimated to be 10<sup>-5 </sup>&#x0003c; k<sub>off </sub>&#x0003c; 10<sup>-3 </sup>[<xref ref-type="bibr" rid="B32">32</xref>]. Analysing the sedimentation velocity of SuhB in the presence of increasing concentrations of Mg<sup>2+</sup>, confirmed that in the absence of Mg<sup>2+ </sup>the monomer form is strongly preferred (Figure <xref ref-type="fig" rid="F6">6A</xref>). Yet, as Mg<sup>2+ </sup>increases in concentration (at a protein concentration of 1.0 mg.ml<sup>-1</sup>) two features are observed: first, the dimer peak increases in height, at the expense of the monomer peak; second, the monomer and dimer peaks shift towards each other until, at 5 mM Mg<sup>2+</sup>, a broad skewed distribution of the sedimentation coefficient is observed (Figure <xref ref-type="fig" rid="F6">6A</xref>), suggesting a gradual transition from slow to fast exchange between the two assembly states due to an increase in the off-rate of dimerisation. Increasing the concentration of Mg<sup>2+ </sup>further, the dimer peak eventually becomes the dominant species in the c(<italic>S</italic>) distribution (Figure <xref ref-type="fig" rid="F6">6A</xref>).</p><fig position="float" id="F6"><label>Figure 6</label><caption><p><bold>Dimerization of SuhB is induced by Mg<sup>2+</sup>, or Mg<sup>2+ </sup>and Li<sup>+</sup>, but not by Li<sup>+ </sup>alone</bold>. Traces of the sedimentation coefficient distribution recorded in sedimentation velocity experiments of <italic>M. tuberculosis </italic>SuhB. SuhB was at 1.0 mg.ml<sup>-1 </sup>in 20 mM Tris-HCl pH 7.9, 50 mM NaCl, plus MgCl<sub>2 </sub>or LiCl as indicated. Samples were centrifuged at 40,000 rpm at 4&#x000b0;C for at least 12 hours. The peak at 1.6 <italic>S </italic>corresponds to a molecular weight of 30,147 Da, the peak at 2.5 <italic>S </italic>corresponds to 50,116 Da.</p></caption><graphic xlink:href="1472-6807-7-55-6"/></fig><p>Next, we examined whether the inhibitor Li<sup>+ </sup>influenced dimerization. At an enzyme concentration of 1.0 mg.ml<sup>-1 </sup>and in the presence of 5 mM Mg<sup>2+</sup>, increasing concentrations of Li<sup>+ </sup>amplify the effect of Mg<sup>2+</sup>-induced dimerization, with the dimer peak becoming dominant over the monomer peak (Figure <xref ref-type="fig" rid="F6">6B</xref>). However on its own Li<sup>+ </sup>promotes dimerization only very weakly, if at all (Figure <xref ref-type="fig" rid="F6">6B</xref>). Furthermore the c(<italic>S</italic>) distribution obtained for 15 mM Mg<sup>2+ </sup>matches almost perfectly the one obtained in presence of 5 mM Mg<sup>2+ </sup>and 5 mM Li<sup>+</sup>. Calcium, which binds to IMPase on identical sites as Mg<sup>2+</sup>, but does not activate, strongly promotes dimerization, while EDTA reverses Mg<sup>2+</sup>-induced dimerization [see Additional file <xref ref-type="supplementary-material" rid="S1">1</xref>].</p></sec></sec><sec><title>Discussion</title><p>The present crystal structure of <italic>M. tuberculosis </italic>SuhB confirms a highly conserved structural scaffold of IMPases in mycobacteria with respect to overall fold and active site geometry, in spite of a low level of overall sequence identity (25%) relative to human IMPase. The structural similarity correlates with similar biochemical characteristics &#x02013; activation by magnesium, inhibition by lithium, specificity for inositol-1-phosphate and exclusion of fructose-1,6-bisphosphate as a substrate. It has been noted previously that the Mg<sup>2+</sup>-dependence of IMPase activity of SuhB resembles more closely that of the thermophilic species <italic>Thermotoga maritima</italic>, <italic>Archeoglobus fulgidus </italic>and <italic>Methanococcus jannaschii </italic>[<xref ref-type="bibr" rid="B12">12</xref>,<xref ref-type="bibr" rid="B25">25</xref>,<xref ref-type="bibr" rid="B33">33</xref>,<xref ref-type="bibr" rid="B34">34</xref>] in that activation is maintained over a concentration range of Mg<sup>2+ </sup>in the order of 100 mM, whereas in eukaryotic IMPases Mg<sup>2+ </sup>becomes inhibitory above 5 mM. Such comparison ignores, however, that unlike these thermophilic enzymes SuhB does not hydrolyze fructose-1,6-bisphosphate, and remains sensitive to Li<sup>+ </sup>(IC<sub>50 </sub>0.9 mM, [<xref ref-type="bibr" rid="B12">12</xref>]). Given that the active site of SuhB, in its 'non-mobile' part, displays the same highly conserved framework of side chains coordinating the three metal sites as the eukaryotic orthologues, we postulate that differences in Mg<sup>2+</sup>-dependence of activity between SuhB and eukaryotic IMPases must be linked on the one hand to structural differences in the mobile &#x003b1;1-&#x003b1;2 loop, and secondly to the apparent link between Mg<sup>2+</sup>-driven dimerization and activation of SuhB. In IMPases and the tetrameric IMPase/FBPases the &#x003b1;1-&#x003b1;2 loop, when ordered, stabilizes the third of the three catalytic metal sites through bridging water molecules [<xref ref-type="bibr" rid="B17">17</xref>,<xref ref-type="bibr" rid="B25">25</xref>,<xref ref-type="bibr" rid="B29">29</xref>]. The &#x003b1;1-&#x003b1;2 loop contributes significantly to the dimer interface. This is apparent when comparing the buried solvent-accessible surface in the dimer interface of human IMPase between the ordered and disordered state of the mobile loop. Thus, we anticipate that ordering of the &#x003b1;1-&#x003b1;2 loop in SuhB, which is 10 residues longer compared to human IMPase, will expand the dimer interface and help stabilize the dimer state. While SuhB is driven to the dimer state at high protein concentrations in the absence of metal ions, as was the case during crystallization, it is evident that Mg<sup>2+ </sup>strongly promotes dimerization at low concentrations. Lithium amplifies the Mg<sup>2+</sup>-induced effect, yet Li<sup>+ </sup>alone does not noticeably shift the monomer dimer equilibrium. These observations correlate with the characteristics of metal binding in the active site, which is known to promote ordering of the &#x003b1;1-&#x003b1;2 loop. According to <sup>7</sup>Li-NMR binding data, lithium occupies a single site per monomer in IMPase [<xref ref-type="bibr" rid="B35">35</xref>], and various indirect evidence points to Li<sup>+ </sup>displacing Mg<sup>2+ </sup>from either site 2 or site 3 [<xref ref-type="bibr" rid="B17">17</xref>,<xref ref-type="bibr" rid="B21">21</xref>,<xref ref-type="bibr" rid="B36">36</xref>,<xref ref-type="bibr" rid="B37">37</xref>]. A lysine residue in the mobile loop (Lys36 in human, open asterisk in Figure <xref ref-type="fig" rid="F1">1</xref>) that coordinates the third metal site via hydrogen bonds to bridging water molecules has been shown to critically influence Li<sup>+</sup>-sensitivity [<xref ref-type="bibr" rid="B37">37</xref>], and this lysine is conserved in SuhB (Lys49). Given that the &#x003b1;1-&#x003b1;2 loop is disordered, the present structure leaves open the precise geometry of this loop in the ordered state and whether Lys49 in SuhB coordinates the third metal site. Yet, lithium sensitivity of SuhB (IC<sub>50 </sub>0.9 mM, [<xref ref-type="bibr" rid="B12">12</xref>]), the debilitating effect on activity of the W234A mutation, and the loss of Li+ inhibition through the L81A mutation [<xref ref-type="bibr" rid="B12">12</xref>] &#x02013; a mutation that removes a stabilising hydrophobic contact to the conserved Trp234 in the active site &#x02013; hint that metal binding induces ordering of the &#x003b1;1-&#x003b1;2 loop in SuhB in a similar fashion as in the eukaryotic orthologues.</p><p>Previously, size exclusion chromatography experiments with 1 mM EDTA present in the buffer had indicated that <italic>E. coli </italic>SuhB formed monomers and it had been inferred that the <italic>E. coli </italic>enzyme was active in the monomeric form [<xref ref-type="bibr" rid="B13">13</xref>]. The parallels between metal-dependent self-association and enzymatic activation in <italic>M. tuberculosis </italic>SuhB strongly suggest that dimerization is linked to loading of the three metal sites in the active site, and that phosphatase activity occurs in the dimer state, although we are not in a position to determine whether dimerization is required for activity. If dimerization were required for enzymatic activity of SuhB, this would at least in part explain the wide range of Mg<sup>2+ </sup>concentrations over which activity is maintained, as the transition to the dimer state is not complete up to at least 15 mM Mg<sup>2+</sup>. Several <italic>caveats </italic>go with this rationale. First, the comparison of the activity and AUC data is complicated by the fact that metal binding is cooperative with substrate binding [<xref ref-type="bibr" rid="B38">38</xref>] and inositol-1-phosphate was not present in the AUC experiments. Also, while dimerisation appears to correlate with loading of the metal positions in the active site, we cannot rule out the possibility that the dimer interface contains one or more metal binding sites, which could drive dimerisation. However, the present structure, in line with related IMPases, and a series of metal-soaking experiments with SuhB crystals provided no indication for such a site (data not shown).</p><p>Crystal structures of eukaryotic IMPases, a refolding study and AUC analysis of human IMPase 2, in the absence of Mg<sup>2+</sup>, consistently indicate constitutive dimerization of the eukaryotic orthologue [<xref ref-type="bibr" rid="B16">16</xref>,<xref ref-type="bibr" rid="B17">17</xref>,<xref ref-type="bibr" rid="B23">23</xref>,<xref ref-type="bibr" rid="B39">39</xref>]. It is not clear what mechanistic purpose dimerization serves with respect to the enzymatic properties of IMPases, and why dimerization should be constitutive in eukarya, but not in bacteria. Unlike the tetrameric FBPases, which are regulated by an allosteric mechanism involving changes in the relative orientation of the subunits in the tetramer (see [<xref ref-type="bibr" rid="B40">40</xref>] and references therein), no regulatory mechanism for IMPase has been reported that invokes dimerization of the enzyme. Nevertheless, Mg<sup>2+ </sup>has been shown to moderately enhance thermal stability of <italic>M. tuberculosis </italic>SuhB, which correlates to some extent with phosphohydrolase activity of SuhB peaking at about 80&#x000b0;C [<xref ref-type="bibr" rid="B12">12</xref>]. While this latter property is mirrored by <italic>E. coli </italic>SuhB [<xref ref-type="bibr" rid="B13">13</xref>] and <italic>M. tuberculosis </italic>CysQ [<xref ref-type="bibr" rid="B15">15</xref>] it has not been tested whether at such high temperatures SuhB still discriminates between substrates. Thus, while dimerization may increase thermal stability, the functional role of Mg<sup>2+</sup>-induced dimerization of SuhB in the physiological regime of the tubercle bacillus is not clear.</p><sec><title>SuhB &#x02013; a template for the other M. tuberculosis IMPases?</title><p>The IMPase-like genes in M. tuberculosis display considerable sequence diversity relative to each other. In the multiple sequence alignment (Figure <xref ref-type="fig" rid="F1">1</xref>), SuhB and Rv3137 align with 30% sequence identity, while ImpA and CysQ score significantly lower (= 23%) relative to any sequence in Figure <xref ref-type="fig" rid="F1">1</xref> (Table <xref ref-type="table" rid="T3">3</xref>). Searching the PDB for homologues of known structure, using BLAST, showed that SuhB still represents the best template in terms of sequence identity, although the differences to the next nearest homologue are small (Table <xref ref-type="table" rid="T3">3</xref>). Based on the search results, one could speculate on the substrate specificities of the two uncharacterised gene products, Rv3137 and ImpA. The gene product with the most divergent sequence, CysQ, has been characterised as a dual IMPase/FBPase [<xref ref-type="bibr" rid="B15">15</xref>]. Consistent with this finding, searching the PDB with the CysQ sequence returns two dual activity enzymes, <italic>Rattus norvegicus </italic>3'-phosphoadenosine-5'-phosphate/inositol-1,4-bisphosphate phosphatase (RnPIP) [<xref ref-type="bibr" rid="B22">22</xref>], and <italic>T. maritima </italic>IMPase/FBPase TM1415 [<xref ref-type="bibr" rid="B18">18</xref>,<xref ref-type="bibr" rid="B27">27</xref>] as the closest homologues of known structure. Likewise, the search results mirror the close relationship of SuhB to the eukaryotic IMPases, which strongly prefer inositol-1-phosphate as substrate. Interestingly, the dual activity IMPase/FBPase TM1415 appears as the top hit for both ImpA and Rv3137 (Table <xref ref-type="table" rid="T3">3</xref>).</p><table-wrap position="float" id="T3"><label>Table 3</label><caption><p>BLAST search for M. tuberculosis IMPase homologues of known structure</p></caption><table frame="hsides" rules="groups"><thead><tr><td></td><td align="left">SuhB</td><td align="left">Rv3137</td><td align="left">ImpA</td><td align="left">CysQ</td><td align="left"><ext-link ext-link-type="pdb" xlink:href="1IMA">1IMA</ext-link><sup>a</sup></td><td align="left"><ext-link ext-link-type="pdb" xlink:href="2BJI">2BJI</ext-link></td><td align="left"><ext-link ext-link-type="pdb" xlink:href="1JP4">1JP4</ext-link></td><td align="left"><ext-link ext-link-type="pdb" xlink:href="2P3N">2P3N</ext-link></td><td align="left"><ext-link ext-link-type="pdb" xlink:href="1G0H">1G0H</ext-link></td></tr></thead><tbody><tr><td align="left">SuhB</td><td align="left">100</td><td align="left">30</td><td align="left">23</td><td align="left">22</td><td align="left">25</td><td align="left">25</td><td align="left">14</td><td align="left">23</td><td align="left">19</td></tr><tr><td align="left">Rv3137</td><td></td><td align="left">100</td><td align="left">23</td><td align="left">18</td><td align="left">23</td><td align="left">22</td><td align="left">22</td><td align="left">29</td><td align="left">17</td></tr><tr><td align="left">ImpA</td><td></td><td></td><td align="left">100</td><td align="left">13</td><td align="left">15</td><td align="left">16</td><td align="left">12</td><td align="left">22</td><td align="left">20</td></tr><tr><td align="left">CysQ</td><td></td><td></td><td></td><td align="left">100</td><td align="left">14</td><td align="left">12</td><td align="left">16</td><td align="left">7</td><td align="left">3</td></tr><tr><td align="left"><ext-link ext-link-type="pdb" xlink:href="1IMA">1IMA</ext-link> (IMP human)</td><td align="left"><bold>2.0E-20</bold></td><td></td><td></td><td></td><td align="left">100</td><td align="left">88</td><td align="left">16</td><td align="left">28</td><td align="left">19</td></tr><tr><td></td><td align="left"><bold>(194)</bold></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td align="left"><ext-link ext-link-type="pdb" xlink:href="2BJI">2BJI</ext-link> (IMP bovine)</td><td align="left"><bold>3.0E-21</bold></td><td align="left"><bold>4.7E-07</bold></td><td></td><td></td><td></td><td align="left">100</td><td align="left">19</td><td align="left">28</td><td align="left">20</td></tr><tr><td></td><td align="left"><bold>(194)</bold></td><td align="left"><bold>(165)</bold></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td align="left"><ext-link ext-link-type="pdb" xlink:href="1JP4">1JP4</ext-link> (PIPase_Rno)</td><td></td><td></td><td></td><td align="left"><bold>2.7E-05</bold></td><td></td><td></td><td align="left">100</td><td align="left">18</td><td align="left">15</td></tr><tr><td></td><td></td><td></td><td></td><td align="left"><bold>(169)</bold></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td align="left"><ext-link ext-link-type="pdb" xlink:href="2P3N">2P3N</ext-link>(TM1415_Tma)</td><td></td><td align="left"><bold>9.5E-16</bold></td><td align="left"><bold>4.0E-12</bold></td><td align="left"><bold>8.7E-04</bold></td><td></td><td></td><td></td><td align="left">100</td><td align="left">23</td></tr><tr><td></td><td></td><td align="left"><bold>(221)</bold></td><td align="left"><bold>(247)</bold></td><td align="left"><bold>(192)</bold></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td align="left"><ext-link ext-link-type="pdb" xlink:href="1G0H">1G0H</ext-link> (MJ0109_Mja)</td><td></td><td></td><td align="left"><bold>6.3E-10</bold></td><td></td><td></td><td></td><td></td><td></td><td align="left">100</td></tr><tr><td></td><td></td><td></td><td align="left"><bold>(161)</bold></td><td></td><td></td><td></td><td></td><td></td><td></td></tr></tbody></table><table-wrap-foot><p>Fields above the table diagonal give the %-identity in a <italic>STRAP</italic>-generated multiple sequence alignment. Fields in bold type give the E-values and (number of paired amino acid residues) of the two top hits in the <italic>BLAST </italic>search of the PDB [48].</p><p><sup>a </sup>References for PDB entries:</p><p><ext-link ext-link-type="pdb" xlink:href="1IMA">1IMA</ext-link> &#x02013; human IMPase complexed with <italic>myo-</italic>inositol-1-phosphate [29]</p><p><ext-link ext-link-type="pdb" xlink:href="2BJI">2BJI</ext-link> &#x02013; bovine IMPase [17]</p><p><ext-link ext-link-type="pdb" xlink:href="1JP4">1JP4</ext-link> &#x02013; <italic>Rattus norvegicus </italic>3'-phosphoadenosine 5'-phosphate and inositol-1,4-bisphosphate phosphatase [22]</p><p><ext-link ext-link-type="pdb" xlink:href="2P3N">2P3N</ext-link> &#x02013; <italic>Thermotoga maritima </italic>TM1415 IMPase/FBPase [27]</p><p><ext-link ext-link-type="pdb" xlink:href="1G0H">1G0H</ext-link> &#x02013; <italic>Methanococcus jannaschii </italic>MJ0109 IMPase/FBPase [24].</p></table-wrap-foot></table-wrap><p>Analysing the multiple sequence alignment that underlies Table <xref ref-type="table" rid="T3">3</xref> [see Additional file <xref ref-type="supplementary-material" rid="S2">2</xref>] more closely, it is interesting to note that enzymes that are specific for inositol-1-phosphate and exclude fructose-1,6-bisphosphate carry a glutamic acid or glutamine at position 228 (SuhB sequence; residue 213 in human IMPase), whereas Asp, His, Ser or Thr are found in enzymes that hydrolyze both substrates or are specific for fructose-1,6-bisphosphate. In the inositol-1-phosphate-bound structure of human IMPase [<xref ref-type="bibr" rid="B29">29</xref>], the corresponding residue, Glu213, forms hydrogen bonds to the C3 and C4 hydroxyls of the inositol ring. In addition to the H-bond between Asp93 (Asp107 in SuhB) and the C6-hydroxyl, these H-bonds are the only side chain-mediated, specificity-determining contacts between the inositol moiety and the enzyme. In the structural superimposition it is evident that an Asp (and likewise Ser, Thr or His) at this position is unlikely to confer selectivity as the distance between the terminal group of the side chain and the sugar hydroxyls becomes too large. Discrimination against fructose-1,6-bisphosphate is rooted primarily in steric clashes of the 6-phosphate the &#x003b2;9-&#x003b1;6 loop. As a result of deletions relative to human IMPase, a much shorter &#x003b2;9-&#x003b1;6 loop in FBPases and dual activity IMPase/FBPases provide the space to accommodate the second phosphate group. Thus, deletions in this region in addition to substitutions of Glu/Gln at position 228 could be indicative of dual specificity. Analysing the sequences of ImpA and Rv3137 in light of these considerations suggests that at least Rv3137 is restricted to inositol-1-phosphate, whereas the case is less clear cut for ImpA. The latter carries a Ser at the position corresponding to Glu228, but displays no significant deletion relative to SuhB between residues 150 and 190, whereas CysQ by the standards of both criteria falls into the category of the dual specificity enzymes, consistent with published biochemical data [<xref ref-type="bibr" rid="B15">15</xref>].</p></sec></sec><sec><title>Conclusion</title><p>We have determined the structure of M. tuberculosis SuhB, providing a structural template for the four IMPase-like enzymes in this organism. While resembling eukaryotic IMPases in terms of structural scaffold, specificity for inositol-1-phosphate, requirement for Mg<sup>2+ </sup>and inhibition by Li<sup>+</sup>, SuhB clearly diverges from the paradigm of constitutive dimerization of <italic>bona fide </italic>IMPases. The present data support a model of Mg<sup>2+</sup>-dependent dimerization, where loading of the three catalytic metal sites in the active site induces ordering of the mobile loop, promoting dimerization likely by expanding the dimer interface. The active site of SuhB presents a highly conserved scaffold of side chains forming the metal- and substrate-binding site, yet additional specificity-determining contacts are expected with the weakly conserved &#x003b2;9-&#x003b1;6 loop. Sequence and structural comparisons lead us to predict that the essential gene product Rv3137 represents a bona fide IMPase, while such may or may not be the case for ImpA.</p></sec><sec sec-type="methods"><title>Methods</title><sec sec-type="materials"><title>Materials</title><p>Centricon YM-10 filtration units were obtained from Millipore. <italic>E. coli </italic>C41(DE3) [<xref ref-type="bibr" rid="B41">41</xref>], acquired from Avidis (France), was used for protein production in this study. Sparse matrix crystallisation screens were obtained from Molecular Dimensions Ltd. All other chemicals were reagent grade or better and obtained from Sigma-Aldrich.</p></sec><sec><title>Expression, purification and crystallisation</title><p>Recombinant proteins were generated and purified as described previously [<xref ref-type="bibr" rid="B12">12</xref>]. Purified His<sub>6</sub>-tagged SuhB, was dialyzed extensively against 20 mM sodium phosphate pH 7.5, 250 mM NaCl and purified further by size exclusion chromatography over a Sephacryl S200-HR matrix. Pure fractions were pooled and concentrated using Centricon YM-10 filter units. Crystals of SuhB were obtained by hanging drop vapour diffusion, mixing 1 &#x003bc;l of protein solution (40&#x02013;50 mg.ml<sup>-1</sup>) with 1 &#x003bc;l of reservoir solution, screening against commercial sparse matrix screens (Structure Screen 1 and 2, Molecular Dimensions Ltd.) at 18&#x000b0;C. Initial crystals appeared in 30%(v/v)2-methyl-2, 4-pentanediol(MPD), 0.1 M tri-sodium citrate, pH 5.6, 0.2 M ammonium acetate. Optimization led to crystals approximately 0.3 mm in length at 10&#x02013;14%(v/v) MPD, 0.1 M citric acid, pH 4.2, and 0.05%(w/v) octyl &#x003b2;-D-glucopyranoside. Crystals grew to their final size over 7&#x02013;10 days. In preparation for X-ray data collection crystals were soaked in cryoprotectant , consisting of upto 30%(v/v) MPD, 125 mM NaCl, 0.1 M citric acid pH 4.2 and 0.05%(w/v) octyl &#x003b2;-D-glucopyranoside, increasing the MPD concentration in steps of 10%. Crystals were mounted in nylon loops and frozen in a 100 K nitrogen gas stream.</p></sec><sec><title>X-ray data collection and crystallographic analysis</title><p>X-ray diffraction data for SuhB were recorded on beamline ID14-EH2 at the European Synchrotron Radiation Facility (ESRF), Grenoble, France (Table <xref ref-type="table" rid="T1">1</xref>). Data were reduced using <italic>DENZO/SCALEPACK </italic>[<xref ref-type="bibr" rid="B42">42</xref>]. Patterson self-rotation analysis (<italic>POLARRFN </italic>&#x02013; [<xref ref-type="bibr" rid="B43">43</xref>]) revealed a 3-fold non-crystallographic rotation axis parallel to the 2<sub>1</sub>-screw axis (resulting in an apparent 6-fold), consistent with three SuhB monomers per crystallographic asymmetric unit. Structure factor amplitudes were normalized (<italic>ECALC </italic>&#x02013; [<xref ref-type="bibr" rid="B43">43</xref>]), and initial phases were obtained by molecular replacement (<italic>AMORE </italic>&#x02013; [<xref ref-type="bibr" rid="B43">43</xref>]), using monomer coordinates of human IMPase (PDB:<ext-link ext-link-type="pdb" xlink:href="1IMA">1IMA</ext-link> &#x02013; [<xref ref-type="bibr" rid="B29">29</xref>]) as a search model. While the Patterson cross-rotation search did not reveal clear solutions, the correct 3 orientations (peaks 4, 5 and 7) could be identified through comparing rotation angles between rotation function peaks with self-rotation peaks, which was confirmed through the subsequent translation search. The search model was stripped of non-conserved side chains and insertions, and built manually into MR-phased density (<italic>O </italic>&#x02013; [<xref ref-type="bibr" rid="B44">44</xref>]). Search model bias was minimised by building into simulated annealing omit maps [<xref ref-type="bibr" rid="B45">45</xref>], followed by rounds of refinement (conjugate-gradient minimization, simulated annealing) in <italic>CNS </italic>ver 1.1 [<xref ref-type="bibr" rid="B46">46</xref>] and manual rebuilding, eventually leading to a model that fitted the data with an Rfree of ~30% (5% of reflections). Non-crystallographic symmetry restraints were introduced and the refinement was continued using <italic>REFMAC5 </italic>[<xref ref-type="bibr" rid="B47">47</xref>]. The final model contains 3 monomers covering SuhB residues 5&#x02013;34, 54&#x02013;85, 98&#x02013;253, 260&#x02013;286. Details of the refinement statistics are listed in Table <xref ref-type="table" rid="T1">1</xref>. Coordinates and structure factors have been deposited in the Protein Data Bank [<xref ref-type="bibr" rid="B48">48</xref>] [PDB:<ext-link ext-link-type="pdb" xlink:href="2Q74">2Q74</ext-link>].</p></sec><sec><title>Molecular graphics</title><p>Figures <xref ref-type="fig" rid="F2">2</xref>, <xref ref-type="fig" rid="F3">3</xref> and <xref ref-type="fig" rid="F4">4A,4B</xref> were prepared using <italic>PyMOL </italic>ver 0.97 [<xref ref-type="bibr" rid="B49">49</xref>]. Figure <xref ref-type="fig" rid="F4">4C</xref> was generated using <italic>Swiss PDB Viewer </italic>[<xref ref-type="bibr" rid="B50">50</xref>] and <italic>POV-Ray </italic>Version 3.6 [<xref ref-type="bibr" rid="B51">51</xref>].</p></sec><sec><title>Analytical ultracentrifugation</title><p>Sedimentation velocity experiments were performed using a Beckman Optima XL-A analytical ultracentrifuge equipped with absorbance optics. Protein samples were dialysed into storage buffer, as indicated in the figure legends (Figures <xref ref-type="fig" rid="F5">5</xref> and <xref ref-type="fig" rid="F6">6</xref>) and loaded into cells with two channel Epon centre pieces and quartz windows. Data were recorded at 40,000 rpm, 4&#x000b0;C. A total of 100 absorbance scans (280 nm) were recorded for each sample, representing the full extent of sedimentation of the sample. Data analysis was performed using the SEDFIT software fitting a single friction coefficient [<xref ref-type="bibr" rid="B52">52</xref>].</p></sec></sec><sec><title>Authors' contributions</title><p>A.K.B., G.S.B. and K.F. designed the study. A.K.B. wrote the initial draft of the manuscript, and purified the protein. G.M. performed crystallisation experiments, data acquisition and contributed to crystallographic analysis and model building. A.K.B. and H.G. performed the AUC experiment, and with help from D.J.S., analysed the data, and prepared figures. L.G.D. together with J.N. designed and produced the expression plasmids, developed the purification protocol and contributed to data interpretation. K.F. solved the structure, contributed to design of figures, and edited the manuscript. All authors have read and approved the manuscript.</p></sec><sec sec-type="supplementary-material"><title>Supplementary Material</title><supplementary-material content-type="local-data" id="S1"><caption><title>Additional file 1</title><p><bold>Supplementary Figure S1</bold>. This Figure shows traces of the sedimentation coefficient distribution recorded in sedimentation velocity experiments of <italic>M. tuberculosis </italic>SuhB. SuhB was at 1.0 mg.ml<sup>-1 </sup>in 20 mM Tris-HCl pH 7.9, 50 mM NaCl, plus MgCl<sub>2</sub>, LiCl, CaCl<sub>2 </sub>and EDTA as indicated. Samples were centrifuged at 40,000 rpm at 4&#x000b0;C for at least 12 hours.</p></caption><media xlink:href="1472-6807-7-55-S1.png" mimetype="image" mime-subtype="png"><caption><p>Click here for file</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="S2"><caption><title>Additional file 2</title><p><bold>Supplementary Figure S2</bold>. This Figure shows a structure-based sequence alignment of IMPase-like proteins using <italic>STRAP </italic>[<xref ref-type="bibr" rid="B53">53</xref>] with formatting in <italic>ESPRIPT </italic>[<xref ref-type="bibr" rid="B54">54</xref>]. Sequence abbreviations (with pdb accession code in parentheses) are as follows: SuhB_Mtb &#x02013; <italic>Mycobacterium tuberculosis </italic>SuhB ; Rv3137_Mtb &#x02013; gene product Rv3131 of <italic>M. tuberculosis; </italic>ImpA_Mtb &#x02013; <italic>M. tuberculosis </italic>ImpA; CysQ_Mtb &#x02013; <italic>M. tuberculosis </italic>CysQ; IMPase_hum &#x02013; human inositol monophosphatase (<ext-link ext-link-type="pdb" xlink:href="1IMA">1IMA</ext-link>); IMPase2_hum &#x02013; human inositol monophosphatase 2 (<ext-link ext-link-type="pdb" xlink:href="2CZH">2CZH</ext-link>); IMPase_bov &#x02013; bovine inositol monophosphatase (<ext-link ext-link-type="pdb" xlink:href="2BJI">2BJI</ext-link>); SuhB_Eco &#x02013; <italic>Escherichia coli </italic>SuhB; MJ0109_Mja &#x02013; <italic>Methanococcus jannaschii </italic>IMPase/FBPase MJ0109 (<ext-link ext-link-type="pdb" xlink:href="1DK4">1DK4</ext-link>); AF2372_Afu &#x02013; <italic>Archeoglobus fulgidus </italic>IMPase/FBPase AF2372 (<ext-link ext-link-type="pdb" xlink:href="1LBV">1LBV</ext-link>); TM1415_Tma &#x02013; <italic>Thermotoga maritima </italic>IMPase TM1415 (<ext-link ext-link-type="pdb" xlink:href="2P3N">2P3N</ext-link>); PIPase_Rno &#x02013; <italic>Rattus norvegicus </italic>3'-phosphoadenosine 5'-phosphate and inositol 1,4-bisphosphate phosphatase (<ext-link ext-link-type="pdb" xlink:href="1JP4">1JP4</ext-link>). Secondary structure elements above the sequence refer to the crystal structure of <italic>M. tuberculosis </italic>SuhB.</p></caption><media xlink:href="1472-6807-7-55-S2.png" mimetype="image" mime-subtype="png"><caption><p>Click here for file</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="S3"><caption><title>Additional file 3</title><p><bold>References for Table </bold><xref ref-type="table" rid="T2">2</xref>. This file contains references for PDB entries cited in Table <xref ref-type="table" rid="T2">2</xref> of the main text.</p></caption><media xlink:href="1472-6807-7-55-S3.pdf" mimetype="application" mime-subtype="pdf"><caption><p>Click here for file</p></caption></media></supplementary-material></sec></body><back><ack><sec><title>Acknowledgements</title><p>We thank Tom Burton for his involvement in model building as part of an undergraduate summer project. We thank Tim Dafforn for access to the analytical ultracentrifuge, part of the Biosciences Biomolecular Characterisation Facility (BBCF), and J. Baz Jackson for valuable discussions. We thank ESRF Grenoble for access to the synchrotron and travel support, and ESRF staff for support during data acquisition. G.M. was supported by an Adrian Brown Scholarship. G.S.B. acknowledges support in the form of a Personal Research Chair from Mr. James Bardrick, as a former Lister Institute-Jenner Research Fellow, and the Medical Research Council.</p></sec></ack><ref-list><ref id="B1"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hallcher</surname><given-names>LM</given-names></name><name><surname>Sherman</surname><given-names>WR</given-names></name></person-group><article-title>The effects of lithium ion and other agents on the activity of myo-inositol-1-phosphatase from bovine brain</article-title><source>J Biol Chem</source><year>1980</year><volume>255</volume><fpage>10896</fpage><lpage>10901</lpage><pub-id pub-id-type="pmid">6253491</pub-id></citation></ref><ref id="B2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Allison</surname><given-names>JH</given-names></name><name><surname>Stewart</surname><given-names>MA</given-names></name></person-group><article-title>Reduced brain inositol in lithium-treated rats</article-title><source>Nat New Biol</source><year>1971</year><volume>233</volume><fpage>267</fpage><lpage>268</lpage><pub-id pub-id-type="pmid">5288124</pub-id><pub-id pub-id-type="doi">10.1038/233330a0</pub-id></citation></ref><ref id="B3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname><given-names>DJ</given-names></name><name><surname>Allemann</surname><given-names>RK</given-names></name></person-group><article-title>myo-Inositol monophosphatase: a challenging target for mood stabilising drugs</article-title><source>Mini Rev Med Chem</source><year>2007</year><volume>7</volume><fpage>107</fpage><lpage>113</lpage><pub-id pub-id-type="pmid">17305585</pub-id><pub-id pub-id-type="doi">10.2174/138955707779802624</pub-id></citation></ref><ref id="B4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Brennan</surname><given-names>PJ</given-names></name><name><surname>Nikaido</surname><given-names>H</given-names></name></person-group><article-title>The envelope of mycobacteria</article-title><source>Annu Rev Biochem</source><year>1995</year><volume>64</volume><fpage>29</fpage><lpage>63</lpage><pub-id pub-id-type="pmid">7574484</pub-id><pub-id pub-id-type="doi">10.1146/annurev.bi.64.070195.000333</pub-id></citation></ref><ref id="B5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chatterjee</surname><given-names>D</given-names></name><name><surname>Khoo</surname><given-names>KH</given-names></name></person-group><article-title>Mycobacterial lipoarabinomannan: an extraordinary lipoheteroglycan with profound physiological effects</article-title><source>Glycobiology</source><year>1998</year><volume>8</volume><fpage>113</fpage><lpage>120</lpage><pub-id pub-id-type="pmid">9451020</pub-id><pub-id pub-id-type="doi">10.1093/glycob/8.2.113</pub-id></citation></ref><ref id="B6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Strohmeier</surname><given-names>GR</given-names></name><name><surname>Fenton</surname><given-names>MJ</given-names></name></person-group><article-title>Roles of lipoarabinomannan in the pathogenesis of tuberculosis</article-title><source>Microbes Infect</source><year>1999</year><volume>1</volume><fpage>709</fpage><lpage>717</lpage><pub-id pub-id-type="pmid">10611748</pub-id><pub-id pub-id-type="doi">10.1016/S1286-4579(99)80072-0</pub-id></citation></ref><ref id="B7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vercellone</surname><given-names>A</given-names></name><name><surname>Nigou</surname><given-names>J</given-names></name><name><surname>Puzo</surname><given-names>G</given-names></name></person-group><article-title>Relationships between the structure and the roles of lipoarabinomannans and related glycoconjugates in tuberculosis pathogenesis</article-title><source>Front Biosci</source><year>1998</year><volume>3</volume><fpage>e149</fpage><lpage>63</lpage><pub-id pub-id-type="pmid">9696885</pub-id></citation></ref><ref id="B8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jackson</surname><given-names>M</given-names></name><name><surname>Crick</surname><given-names>DC</given-names></name><name><surname>Brennan</surname><given-names>PJ</given-names></name></person-group><article-title>Phosphatidylinositol is an essential phospholipid of mycobacteria</article-title><source>J Biol Chem</source><year>2000</year><volume>275</volume><fpage>30092</fpage><lpage>30099</lpage><pub-id pub-id-type="pmid">10889206</pub-id><pub-id pub-id-type="doi">10.1074/jbc.M004658200</pub-id></citation></ref><ref id="B9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>IW</given-names></name><name><surname>Charalampous</surname><given-names>CF</given-names></name></person-group><article-title>Biochemical studies on inositol. IX. D-Inositol 1-phosphate as intermediate in the biosynthesis of inositol from glucose 6-phosphate, and characteristics of two reactions in this biosynthesis</article-title><source>J Biol Chem</source><year>1966</year><volume>241</volume><fpage>2194</fpage><lpage>2199</lpage><pub-id pub-id-type="pmid">4287852</pub-id></citation></ref><ref id="B10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nigou</surname><given-names>J</given-names></name><name><surname>Besra</surname><given-names>GS</given-names></name></person-group><article-title>Characterization and regulation of inositol monophosphatase activity in Mycobacterium smegmatis</article-title><source>Biochem J</source><year>2002</year><volume>361</volume><fpage>385</fpage><lpage>390</lpage><pub-id pub-id-type="pmid">11772411</pub-id></citation></ref><ref id="B11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cole</surname><given-names>ST</given-names></name><name><surname>Brosch</surname><given-names>R</given-names></name><name><surname>Parkhill</surname><given-names>J</given-names></name><name><surname>Garnier</surname><given-names>T</given-names></name><name><surname>Churcher</surname><given-names>C</given-names></name><name><surname>Harris</surname><given-names>D</given-names></name><name><surname>Gordon</surname><given-names>SV</given-names></name><name><surname>Eiglmeier</surname><given-names>K</given-names></name><name><surname>Gas</surname><given-names>S</given-names></name><name><surname>Barry</surname><given-names>CEr</given-names></name><name><surname>Tekaia</surname><given-names>F</given-names></name><name><surname>Badcock</surname><given-names>K</given-names></name><name><surname>Basham</surname><given-names>D</given-names></name><name><surname>Brown</surname><given-names>D</given-names></name><name><surname>Chillingworth</surname><given-names>T</given-names></name><name><surname>Connor</surname><given-names>R</given-names></name><name><surname>Davies</surname><given-names>R</given-names></name><name><surname>Devlin</surname><given-names>K</given-names></name><name><surname>Feltwell</surname><given-names>T</given-names></name><name><surname>Gentles</surname><given-names>S</given-names></name><name><surname>Hamlin</surname><given-names>N</given-names></name><name><surname>Holroyd</surname><given-names>S</given-names></name><name><surname>Hornsby</surname><given-names>T</given-names></name><name><surname>Jagels</surname><given-names>K</given-names></name><name><surname>Krogh</surname><given-names>A</given-names></name><name><surname>McLean</surname><given-names>J</given-names></name><name><surname>Moule</surname><given-names>S</given-names></name><name><surname>Murphy</surname><given-names>L</given-names></name><name><surname>Oliver</surname><given-names>K</given-names></name><name><surname>Osborne</surname><given-names>J</given-names></name><name><surname>Quail</surname><given-names>MA</given-names></name><name><surname>Rajandream</surname><given-names>MA</given-names></name><name><surname>Rogers</surname><given-names>J</given-names></name><name><surname>Rutter</surname><given-names>S</given-names></name><name><surname>Seeger</surname><given-names>K</given-names></name><name><surname>Skelton</surname><given-names>J</given-names></name><name><surname>Squares</surname><given-names>R</given-names></name><name><surname>Squares</surname><given-names>S</given-names></name><name><surname>Sulston</surname><given-names>JE</given-names></name><name><surname>Taylor</surname><given-names>K</given-names></name><name><surname>Whitehead</surname><given-names>S</given-names></name><name><surname>Barrell</surname><given-names>BG</given-names></name></person-group><article-title>Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence</article-title><source>Nature</source><year>1998</year><volume>393</volume><fpage>537</fpage><lpage>544</lpage><pub-id pub-id-type="pmid">9634230</pub-id><pub-id pub-id-type="doi">10.1038/31159</pub-id></citation></ref><ref id="B12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nigou</surname><given-names>J</given-names></name><name><surname>Dover</surname><given-names>LG</given-names></name><name><surname>Besra</surname><given-names>GS</given-names></name></person-group><article-title>Purification and biochemical characterization of Mycobacterium tuberculosis SuhB, an inositol monophosphatase involved in inositol biosynthesis</article-title><source>Biochemistry</source><year>2002</year><volume>41</volume><fpage>4392</fpage><lpage>4398</lpage><pub-id pub-id-type="pmid">11914086</pub-id><pub-id pub-id-type="doi">10.1021/bi0160056</pub-id></citation></ref><ref id="B13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>Roberts</surname><given-names>MF</given-names></name></person-group><article-title>Overexpression, purification, and analysis of complementation behavior of E. coli SuhB protein: comparison with bacterial and archaeal inositol monophosphatases</article-title><source>Biochemistry</source><year>2000</year><volume>39</volume><fpage>4145</fpage><lpage>4153</lpage><pub-id pub-id-type="pmid">10747806</pub-id><pub-id pub-id-type="doi">10.1021/bi992424f</pub-id></citation></ref><ref id="B14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sassetti</surname><given-names>CM</given-names></name><name><surname>Boyd</surname><given-names>DH</given-names></name><name><surname>Rubin</surname><given-names>EJ</given-names></name></person-group><article-title>Genes required for mycobacterial growth defined by high density mutagenesis</article-title><source>Mol Microbiol</source><year>2003</year><volume>48</volume><fpage>77</fpage><lpage>84</lpage><pub-id pub-id-type="pmid">12657046</pub-id><pub-id pub-id-type="doi">10.1046/j.1365-2958.2003.03425.x</pub-id></citation></ref><ref id="B15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gu</surname><given-names>X</given-names></name><name><surname>Chen</surname><given-names>M</given-names></name><name><surname>Shen</surname><given-names>H</given-names></name><name><surname>Jiang</surname><given-names>X</given-names></name><name><surname>Huang</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name></person-group><article-title>Rv2131c gene product: an unconventional enzyme that is both inositol monophosphatase and fructose-1,6-bisphosphatase</article-title><source>Biochem Biophys Res Commun</source><year>2006</year><volume>339</volume><fpage>897</fpage><lpage>904</lpage><pub-id pub-id-type="pmid">16325768</pub-id><pub-id pub-id-type="doi">10.1016/j.bbrc.2005.11.088</pub-id></citation></ref><ref id="B16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bone</surname><given-names>R</given-names></name><name><surname>Springer</surname><given-names>JP</given-names></name><name><surname>Atack</surname><given-names>JR</given-names></name></person-group><article-title>Structure of inositol monophosphatase, the putative target of lithium therapy</article-title><source>Proc Natl Acad Sci U S A</source><year>1992</year><volume>89</volume><fpage>10031</fpage><lpage>10035</lpage><pub-id pub-id-type="pmid">1332026</pub-id><pub-id pub-id-type="doi">10.1073/pnas.89.21.10031</pub-id></citation></ref><ref id="B17"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gill</surname><given-names>R</given-names></name><name><surname>Mohammed</surname><given-names>F</given-names></name><name><surname>Badyal</surname><given-names>R</given-names></name><name><surname>Coates</surname><given-names>L</given-names></name><name><surname>Erskine</surname><given-names>P</given-names></name><name><surname>Thompson</surname><given-names>D</given-names></name><name><surname>Cooper</surname><given-names>J</given-names></name><name><surname>Gore</surname><given-names>M</given-names></name><name><surname>Wood</surname><given-names>S</given-names></name></person-group><article-title>High-resolution structure of myo-inositol monophosphatase, the putative target of lithium therapy</article-title><source>Acta Crystallogr D Biol Crystallogr</source><year>2005</year><volume>61</volume><fpage>545</fpage><lpage>555</lpage><pub-id pub-id-type="pmid">15858264</pub-id><pub-id pub-id-type="doi">10.1107/S0907444905004038</pub-id></citation></ref><ref id="B18"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Stec</surname><given-names>B</given-names></name><name><surname>Yang</surname><given-names>H</given-names></name><name><surname>Johnson</surname><given-names>KA</given-names></name><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>Roberts</surname><given-names>MF</given-names></name></person-group><article-title>MJ0109 is an enzyme that is both an inositol monophosphatase and the 'missing' archaeal fructose-1,6-bisphosphatase</article-title><source>Nat Struct Biol</source><year>2000</year><volume>7</volume><fpage>1046</fpage><lpage>1050</lpage><pub-id pub-id-type="pmid">11062561</pub-id><pub-id pub-id-type="doi">10.1038/80968</pub-id></citation></ref><ref id="B19"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>York</surname><given-names>JD</given-names></name><name><surname>Ponder</surname><given-names>JW</given-names></name><name><surname>Majerus</surname><given-names>PW</given-names></name></person-group><article-title>Definition of a metal-dependent/Li(+)-inhibited phosphomonoesterase protein family based upon a conserved three-dimensional core structure</article-title><source>Proc Natl Acad Sci U S A</source><year>1995</year><volume>92</volume><fpage>5149</fpage><lpage>5153</lpage><pub-id pub-id-type="pmid">7761465</pub-id><pub-id pub-id-type="doi">10.1073/pnas.92.11.5149</pub-id></citation></ref><ref id="B20"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Liang</surname><given-names>JY</given-names></name><name><surname>Lipscomb</surname><given-names>WN</given-names></name></person-group><article-title>Structural similarities between fructose-1,6-bisphosphatase and inositol monophosphatase</article-title><source>Biochem Biophys Res Commun</source><year>1993</year><volume>190</volume><fpage>1080</fpage><lpage>1083</lpage><pub-id pub-id-type="pmid">8382485</pub-id><pub-id pub-id-type="doi">10.1006/bbrc.1993.1159</pub-id></citation></ref><ref id="B21"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Albert</surname><given-names>A</given-names></name><name><surname>Yenush</surname><given-names>L</given-names></name><name><surname>Gil-Mascarell</surname><given-names>MR</given-names></name><name><surname>Rodriguez</surname><given-names>PL</given-names></name><name><surname>Patel</surname><given-names>S</given-names></name><name><surname>Martinez-Ripoll</surname><given-names>M</given-names></name><name><surname>Blundell</surname><given-names>TL</given-names></name><name><surname>Serrano</surname><given-names>R</given-names></name></person-group><article-title>X-ray structure of yeast Hal2p, a major target of lithium and sodium toxicity, and identification of framework interactions determining cation sensitivity</article-title><source>J Mol Biol</source><year>2000</year><volume>295</volume><fpage>927</fpage><lpage>938</lpage><pub-id pub-id-type="pmid">10656801</pub-id><pub-id pub-id-type="doi">10.1006/jmbi.1999.3408</pub-id></citation></ref><ref id="B22"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Patel</surname><given-names>S</given-names></name><name><surname>Yenush</surname><given-names>L</given-names></name><name><surname>Rodriguez</surname><given-names>PL</given-names></name><name><surname>Serrano</surname><given-names>R</given-names></name><name><surname>Blundell</surname><given-names>TL</given-names></name></person-group><article-title>Crystal structure of an enzyme displaying both inositol-polyphosphate-1-phosphatase and 3'-phosphoadenosine-5'-phosphate phosphatase activities: a novel target of lithium therapy</article-title><source>J Mol Biol</source><year>2002</year><volume>315</volume><fpage>677</fpage><lpage>685</lpage><pub-id pub-id-type="pmid">11812139</pub-id><pub-id pub-id-type="doi">10.1006/jmbi.2001.5271</pub-id></citation></ref><ref id="B23"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Arai</surname><given-names>R</given-names></name><name><surname>Ito</surname><given-names>K</given-names></name><name><surname>Ohnishi</surname><given-names>T</given-names></name><name><surname>Ohba</surname><given-names>H</given-names></name><name><surname>Akasaka</surname><given-names>R</given-names></name><name><surname>Bessho</surname><given-names>Y</given-names></name><name><surname>Hanawa-Suetsugu</surname><given-names>K</given-names></name><name><surname>Yoshikawa</surname><given-names>T</given-names></name><name><surname>Shirouzu</surname><given-names>M</given-names></name><name><surname>Yokoyama</surname><given-names>S</given-names></name></person-group><article-title>Crystal structure of human myo-inositol monophosphatase 2, the product of the putative susceptibility gene for bipolar disorder, schizophrenia, and febrile seizures</article-title><source>Proteins</source><year>2007</year><volume>67</volume><fpage>732</fpage><lpage>742</lpage><pub-id pub-id-type="pmid">17340635</pub-id><pub-id pub-id-type="doi">10.1002/prot.21299</pub-id></citation></ref><ref id="B24"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname><given-names>KA</given-names></name><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>Yang</surname><given-names>H</given-names></name><name><surname>Roberts</surname><given-names>MF</given-names></name><name><surname>Stec</surname><given-names>B</given-names></name></person-group><article-title>Crystal structure and catalytic mechanism of the MJ0109 gene product: a bifunctional enzyme with inositol monophosphatase and fructose 1,6-bisphosphatase activities</article-title><source>Biochemistry</source><year>2001</year><volume>40</volume><fpage>618</fpage><lpage>630</lpage><pub-id pub-id-type="pmid">11170378</pub-id><pub-id pub-id-type="doi">10.1021/bi0016422</pub-id></citation></ref><ref id="B25"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Stieglitz</surname><given-names>KA</given-names></name><name><surname>Johnson</surname><given-names>KA</given-names></name><name><surname>Yang</surname><given-names>H</given-names></name><name><surname>Roberts</surname><given-names>MF</given-names></name><name><surname>Seaton</surname><given-names>BA</given-names></name><name><surname>Head</surname><given-names>JF</given-names></name><name><surname>Stec</surname><given-names>B</given-names></name></person-group><article-title>Crystal structure of a dual activity IMPase/FBPase (AF2372) from Archaeoglobus fulgidus. The story of a mobile loop</article-title><source>J Biol Chem</source><year>2002</year><volume>277</volume><fpage>22863</fpage><lpage>22874</lpage><pub-id pub-id-type="pmid">11940584</pub-id><pub-id pub-id-type="doi">10.1074/jbc.M201042200</pub-id></citation></ref><ref id="B26"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ke</surname><given-names>HM</given-names></name><name><surname>Zhang</surname><given-names>YP</given-names></name><name><surname>Lipscomb</surname><given-names>WN</given-names></name></person-group><article-title>Crystal structure of fructose-1,6-bisphosphatase complexed with fructose 6-phosphate, AMP, and magnesium</article-title><source>Proc Natl Acad Sci U S A</source><year>1990</year><volume>87</volume><fpage>5243</fpage><lpage>5247</lpage><pub-id pub-id-type="pmid">2164670</pub-id><pub-id pub-id-type="doi">10.1073/pnas.87.14.5243</pub-id></citation></ref><ref id="B27"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Stieglitz</surname><given-names>KA</given-names></name><name><surname>Roberts</surname><given-names>MF</given-names></name><name><surname>Li</surname><given-names>W</given-names></name><name><surname>Stec</surname><given-names>B</given-names></name></person-group><article-title>Crystal structure of the tetrameric inositol 1-phosphate phosphatase (TM1415) from the hyperthermophile, Thermotoga maritima</article-title><source>FEBS J</source><year>2007</year><volume>274</volume><fpage>2461</fpage><lpage>2469</lpage><pub-id pub-id-type="pmid">17419729</pub-id><pub-id pub-id-type="doi">10.1111/j.0014-2956.2007.05779.x</pub-id></citation></ref><ref id="B28"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bone</surname><given-names>R</given-names></name><name><surname>Frank</surname><given-names>L</given-names></name><name><surname>Springer</surname><given-names>JP</given-names></name><name><surname>Atack</surname><given-names>JR</given-names></name></person-group><article-title>Structural studies of metal binding by inositol monophosphatase: evidence for two-metal ion catalysis</article-title><source>Biochemistry</source><year>1994</year><volume>33</volume><fpage>9468</fpage><lpage>9476</lpage><pub-id pub-id-type="pmid">8068621</pub-id><pub-id pub-id-type="doi">10.1021/bi00198a012</pub-id></citation></ref><ref id="B29"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bone</surname><given-names>R</given-names></name><name><surname>Frank</surname><given-names>L</given-names></name><name><surname>Springer</surname><given-names>JP</given-names></name><name><surname>Pollack</surname><given-names>SJ</given-names></name><name><surname>Osborne</surname><given-names>SA</given-names></name><name><surname>Atack</surname><given-names>JR</given-names></name><name><surname>Knowles</surname><given-names>MR</given-names></name><name><surname>McAllister</surname><given-names>G</given-names></name><name><surname>Ragan</surname><given-names>CI</given-names></name><name><surname>Broughton</surname><given-names>HB</given-names></name><etal></etal></person-group><article-title>Structural analysis of inositol monophosphatase complexes with substrates</article-title><source>Biochemistry</source><year>1994</year><volume>33</volume><fpage>9460</fpage><lpage>9467</lpage><pub-id pub-id-type="pmid">8068620</pub-id><pub-id pub-id-type="doi">10.1021/bi00198a011</pub-id></citation></ref><ref id="B30"><citation citation-type="other"><article-title>Protein interfaces, surfaces and assemblies service PISA at European Bioinformatics Institute</article-title><ext-link ext-link-type="uri" xlink:href="http://www.ebi.ac.uk/msd-srv/prot_int/pistart.html"/></citation></ref><ref id="B31"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Krissinel</surname><given-names>E</given-names></name><name><surname>Henrick</surname><given-names>K</given-names></name></person-group><article-title>Inference of macromolecular assemblies from crystallline state</article-title><source>J Mol Biol</source><year>2007</year><comment>doi:10.1016/j.jmb.2007.05.022:available online 13 May 2007.</comment><pub-id pub-id-type="pmid">17681537</pub-id></citation></ref><ref id="B32"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schuck</surname><given-names>P</given-names></name></person-group><article-title>On the analysis of protein self-association by sedimentation velocity analytical ultracentrifugation</article-title><source>Anal Biochem</source><year>2003</year><volume>320</volume><fpage>104</fpage><lpage>124</lpage><pub-id pub-id-type="pmid">12895474</pub-id><pub-id pub-id-type="doi">10.1016/S0003-2697(03)00289-6</pub-id></citation></ref><ref id="B33"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>Roberts</surname><given-names>MF</given-names></name></person-group><article-title>Cloning and expression of the inositol monophosphatase gene from Methanococcus jannaschii and characterization of the enzyme</article-title><source>Appl Environ Microbiol</source><year>1998</year><volume>64</volume><fpage>2609</fpage><lpage>2615</lpage><pub-id pub-id-type="pmid">9647837</pub-id></citation></ref><ref id="B34"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>Roberts</surname><given-names>MF</given-names></name></person-group><article-title>Characterization of a tetrameric inositol monophosphatase from the hyperthermophilic bacterium Thermotoga maritima</article-title><source>Appl Environ Microbiol</source><year>1999</year><volume>65</volume><fpage>4559</fpage><lpage>4567</lpage><pub-id pub-id-type="pmid">10508089</pub-id></citation></ref><ref id="B35"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Saudek</surname><given-names>V</given-names></name><name><surname>Vicendon</surname><given-names>P</given-names></name><name><surname>Do</surname><given-names>QT</given-names></name><name><surname>Atkinson</surname><given-names>RA</given-names></name><name><surname>Sklenar</surname><given-names>V</given-names></name><name><surname>Pelton</surname><given-names>PD</given-names></name><name><surname>Piriou</surname><given-names>F</given-names></name><name><surname>Ganzhorn</surname><given-names>AJ</given-names></name></person-group><article-title>7Li nuclear-magnetic-resonance study of lithium binding to myo-inositolmonophosphatase</article-title><source>Eur J Biochem</source><year>1996</year><volume>240</volume><fpage>288</fpage><lpage>291</lpage><pub-id pub-id-type="pmid">8925839</pub-id></citation></ref><ref id="B36"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ganzhorn</surname><given-names>AJ</given-names></name><name><surname>Chanal</surname><given-names>MC</given-names></name></person-group><article-title>Kinetic studies with myo-inositol monophosphatase from bovine brain</article-title><source>Biochemistry</source><year>1990</year><volume>29</volume><fpage>6065</fpage><lpage>6071</lpage><pub-id pub-id-type="pmid">2166573</pub-id><pub-id pub-id-type="doi">10.1021/bi00477a026</pub-id></citation></ref><ref id="B37"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ganzhorn</surname><given-names>AJ</given-names></name><name><surname>Lepage</surname><given-names>P</given-names></name><name><surname>Pelton</surname><given-names>PD</given-names></name><name><surname>Strasser</surname><given-names>F</given-names></name><name><surname>Vincendon</surname><given-names>P</given-names></name><name><surname>Rondeau</surname><given-names>JM</given-names></name></person-group><article-title>The contribution of lysine-36 to catalysis by human myo-inositol monophosphatase</article-title><source>Biochemistry</source><year>1996</year><volume>35</volume><fpage>10957</fpage><lpage>10966</lpage><pub-id pub-id-type="pmid">8718889</pub-id><pub-id pub-id-type="doi">10.1021/bi9603837</pub-id></citation></ref><ref id="B38"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Strasser</surname><given-names>F</given-names></name><name><surname>Pelton</surname><given-names>PD</given-names></name><name><surname>Ganzhorn</surname><given-names>AJ</given-names></name></person-group><article-title>Kinetic characterization of enzyme forms involved in metal ion activation and inhibition of myo-inositol monophosphatase</article-title><source>Biochem J</source><year>1995</year><volume>307</volume><fpage>585</fpage><lpage>593</lpage><pub-id pub-id-type="pmid">7733900</pub-id></citation></ref><ref id="B39"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kwon</surname><given-names>OS</given-names></name><name><surname>Lo</surname><given-names>SC</given-names></name><name><surname>Kwok</surname><given-names>F</given-names></name><name><surname>Churchich</surname><given-names>JE</given-names></name></person-group><article-title>Reversible unfolding of myo-inositol monophosphatase</article-title><source>J Biol Chem</source><year>1993</year><volume>268</volume><fpage>7912</fpage><lpage>7916</lpage><pub-id pub-id-type="pmid">8385126</pub-id></citation></ref><ref id="B40"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hines</surname><given-names>JK</given-names></name><name><surname>Fromm</surname><given-names>HJ</given-names></name><name><surname>Honzatko</surname><given-names>RB</given-names></name></person-group><article-title>Novel allosteric activation site in Escherichia coli fructose-1,6-bisphosphatase</article-title><source>J Biol Chem</source><year>2006</year><volume>281</volume><fpage>18386</fpage><lpage>18393</lpage><pub-id pub-id-type="pmid">16670087</pub-id><pub-id pub-id-type="doi">10.1074/jbc.M602553200</pub-id></citation></ref><ref id="B41"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Miroux</surname><given-names>B</given-names></name><name><surname>Walker</surname><given-names>JE</given-names></name></person-group><article-title>Over-production of proteins in Escherichia coli: mutant hosts that allow synthesis of some membrane proteins and globular proteins at high levels</article-title><source>J Mol Biol</source><year>1996</year><volume>260</volume><fpage>289</fpage><lpage>298</lpage><pub-id pub-id-type="pmid">8757792</pub-id><pub-id pub-id-type="doi">10.1006/jmbi.1996.0399</pub-id></citation></ref><ref id="B42"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Otwinowski</surname><given-names>Z</given-names></name><name><surname>Minor</surname><given-names>W</given-names></name></person-group><article-title>Processing of X-ray diffraction data collected in oscillation mode</article-title><source>Methods Enzymol</source><year>1997</year><volume>276</volume><fpage>307</fpage><lpage>326</lpage></citation></ref><ref id="B43"><citation citation-type="journal"><person-group person-group-type="author"><collab>CCP4</collab></person-group><article-title>The CCP4 suite: programs for protein crystallography</article-title><source>Acta Crystallogr D Biol Crystallogr</source><year>1994</year><volume>50</volume><fpage>760</fpage><lpage>763</lpage><pub-id pub-id-type="pmid">15299374</pub-id><pub-id pub-id-type="doi">10.1107/S0907444994003112</pub-id></citation></ref><ref id="B44"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jones</surname><given-names>TA</given-names></name><name><surname>Zou</surname><given-names>JY</given-names></name><name><surname>Cowan</surname><given-names>SW</given-names></name><name><surname>Kjeldgaard</surname><given-names>M</given-names></name></person-group><article-title>Improved methods for building protein models in electron density maps and the location of errors in these models</article-title><source>Acta Crystallogr A</source><year>1991</year><volume>47</volume><fpage>110</fpage><lpage>119</lpage><pub-id pub-id-type="pmid">2025413</pub-id><pub-id pub-id-type="doi">10.1107/S0108767390010224</pub-id></citation></ref><ref id="B45"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hodel</surname><given-names>A</given-names></name><name><surname>Kim</surname><given-names>S-H</given-names></name><name><surname>Br&#x000fc;nger</surname><given-names>AT</given-names></name></person-group><article-title>Model bias in crystal structures</article-title><source>Acta Crystallogr A</source><year>1992</year><volume>48</volume><fpage>851</fpage><lpage>858</lpage><pub-id pub-id-type="doi">10.1107/S0108767392006044</pub-id></citation></ref><ref id="B46"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Brunger</surname><given-names>AT</given-names></name><name><surname>Adams</surname><given-names>PD</given-names></name><name><surname>Clore</surname><given-names>GM</given-names></name><name><surname>DeLano</surname><given-names>WL</given-names></name><name><surname>Gros</surname><given-names>P</given-names></name><name><surname>Grosse-Kunstleve</surname><given-names>RW</given-names></name><name><surname>Jiang</surname><given-names>JS</given-names></name><name><surname>Kuszewski</surname><given-names>J</given-names></name><name><surname>Nilges</surname><given-names>M</given-names></name><name><surname>Pannu</surname><given-names>NS</given-names></name><name><surname>Read</surname><given-names>RJ</given-names></name><name><surname>Rice</surname><given-names>LM</given-names></name><name><surname>Simonson</surname><given-names>T</given-names></name><name><surname>Warren</surname><given-names>GL</given-names></name></person-group><article-title>Crystallography &#x00026; NMR system: A new software suite for macromolecular structure determination</article-title><source>Acta Crystallogr D Biol Crystallogr</source><year>1998</year><volume>54</volume><fpage>905</fpage><lpage>921</lpage><pub-id pub-id-type="pmid">9757107</pub-id><pub-id pub-id-type="doi">10.1107/S0907444998003254</pub-id></citation></ref><ref id="B47"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Murshudov</surname><given-names>GN</given-names></name><name><surname>Vagin</surname><given-names>AA</given-names></name><name><surname>Dodson</surname><given-names>EJ</given-names></name></person-group><article-title>Refinement of macromolecular structures by the maximum-likelihood method</article-title><source>Acta Crystallogr D Biol Crystallogr</source><year>1997</year><volume>53</volume><fpage>240</fpage><lpage>255</lpage><pub-id pub-id-type="pmid">15299926</pub-id><pub-id pub-id-type="doi">10.1107/S0907444996012255</pub-id></citation></ref><ref id="B48"><citation citation-type="other"><article-title>The RCSB Protein Data Bank (PDB)</article-title><ext-link ext-link-type="uri" xlink:href="http://www.rcsb.org"/></citation></ref><ref id="B49"><citation citation-type="other"><article-title>The PyMOL Molecular Graphics System</article-title><ext-link ext-link-type="uri" xlink:href="http://www.pymol.org"/></citation></ref><ref id="B50"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schwede</surname><given-names>T</given-names></name><name><surname>Diemand</surname><given-names>A</given-names></name><name><surname>Guex</surname><given-names>N</given-names></name><name><surname>Peitsch</surname><given-names>MC</given-names></name></person-group><article-title>Protein structure computing in the genomic era</article-title><source>Res Microbiol</source><year>2000</year><volume>151</volume><fpage>107</fpage><lpage>112</lpage><pub-id pub-id-type="pmid">10865955</pub-id><pub-id pub-id-type="doi">10.1016/S0923-2508(00)00121-2</pub-id></citation></ref><ref id="B51"><citation citation-type="other"><article-title>PovRay &#x02013; Persistence of Vision Raytracer</article-title><ext-link ext-link-type="uri" xlink:href="http://www.povray.org"/></citation></ref><ref id="B52"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schuck</surname><given-names>P</given-names></name></person-group><article-title>Size-distribution analysis of macromolecules by sedimentation velocity ultracentrifugation and lamm equation modeling</article-title><source>Biophys J</source><year>2000</year><volume>78</volume><fpage>1606</fpage><lpage>1619</lpage><pub-id pub-id-type="pmid">10692345</pub-id></citation></ref><ref id="B53"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gille</surname><given-names>C</given-names></name><name><surname>Frommel</surname><given-names>C</given-names></name></person-group><article-title>STRAP: editor for STRuctural Alignments of Proteins</article-title><source>Bioinformatics</source><year>2001</year><volume>17</volume><fpage>377</fpage><lpage>378</lpage><pub-id pub-id-type="pmid">11301311</pub-id><pub-id pub-id-type="doi">10.1093/bioinformatics/17.4.377</pub-id></citation></ref><ref id="B54"><citation citation-type="other"><article-title>ESPript, Easy Sequencing in Postscript</article-title><ext-link ext-link-type="uri" xlink:href="http://espript.ibcp.fr/ESPript/ESPript/"/></citation></ref></ref-list></back></article> 